000175178812/312021Q2false000002991512/312021Q2false00017517882021-01-012021-06-300001751788dow:TheDowChemicalCompanyMember2021-01-012021-06-300001751788dow:A0500NotesDueMarch152027Memberdow:TheDowChemicalCompanyMember2021-01-012021-06-300001751788dow:A1125NotesDueMarch152032Memberdow:TheDowChemicalCompanyMember2021-01-012021-06-300001751788dow:TheDowChemicalCompanyMemberdow:A1875NotesDueMarch152040Member2021-01-012021-06-300001751788dow:TheDowChemicalCompanyMemberdow:A4625NotesDueOctober12044Member2021-01-012021-06-30xbrli:shares00017517882021-06-30iso4217:USDxbrli:shares0001751788dow:TheDowChemicalCompanyMember2021-06-30iso4217:USD00017517882021-04-012021-06-3000017517882020-04-012020-06-3000017517882020-01-012020-06-300001751788us-gaap:VariableInterestEntityPrimaryBeneficiaryMember2021-06-300001751788us-gaap:VariableInterestEntityPrimaryBeneficiaryMember2020-12-3100017517882020-12-3100017517882019-12-3100017517882020-06-300001751788us-gaap:CommonStockMember2021-03-310001751788us-gaap:CommonStockMember2020-03-310001751788us-gaap:CommonStockMember2021-06-300001751788us-gaap:CommonStockMember2020-12-310001751788us-gaap:CommonStockMember2020-06-300001751788us-gaap:CommonStockMember2019-12-310001751788us-gaap:AdditionalPaidInCapitalMember2021-03-310001751788us-gaap:AdditionalPaidInCapitalMember2020-03-310001751788us-gaap:AdditionalPaidInCapitalMember2020-12-310001751788us-gaap:AdditionalPaidInCapitalMember2019-12-310001751788us-gaap:AdditionalPaidInCapitalMember2021-04-012021-06-300001751788us-gaap:AdditionalPaidInCapitalMember2020-04-012020-06-300001751788us-gaap:AdditionalPaidInCapitalMember2021-01-012021-06-300001751788us-gaap:AdditionalPaidInCapitalMember2020-01-012020-06-300001751788us-gaap:AdditionalPaidInCapitalMember2021-06-300001751788us-gaap:AdditionalPaidInCapitalMember2020-06-300001751788us-gaap:RetainedEarningsMember2021-03-310001751788us-gaap:RetainedEarningsMember2020-03-310001751788us-gaap:RetainedEarningsMember2020-12-310001751788us-gaap:RetainedEarningsMember2019-12-310001751788us-gaap:RetainedEarningsMember2021-04-012021-06-300001751788us-gaap:RetainedEarningsMember2020-04-012020-06-300001751788us-gaap:RetainedEarningsMember2021-01-012021-06-300001751788us-gaap:RetainedEarningsMember2020-01-012020-06-300001751788us-gaap:RetainedEarningsMember2021-06-300001751788us-gaap:RetainedEarningsMember2020-06-300001751788us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-03-310001751788us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-03-310001751788us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-12-310001751788us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-12-310001751788us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-04-012021-06-300001751788us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-04-012020-06-300001751788us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-01-012021-06-300001751788us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-01-012020-06-300001751788us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-06-300001751788us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-06-300001751788dow:UnearnedEsopSharesMember2021-03-310001751788dow:UnearnedEsopSharesMember2020-03-310001751788dow:UnearnedEsopSharesMember2020-12-310001751788dow:UnearnedEsopSharesMember2019-12-310001751788dow:UnearnedEsopSharesMember2021-04-012021-06-300001751788dow:UnearnedEsopSharesMember2020-04-012020-06-300001751788dow:UnearnedEsopSharesMember2021-01-012021-06-300001751788dow:UnearnedEsopSharesMember2020-01-012020-06-300001751788dow:UnearnedEsopSharesMember2021-06-300001751788dow:UnearnedEsopSharesMember2020-06-300001751788us-gaap:TreasuryStockMember2021-03-310001751788us-gaap:TreasuryStockMember2020-03-310001751788us-gaap:TreasuryStockMember2020-12-310001751788us-gaap:TreasuryStockMember2019-12-310001751788us-gaap:TreasuryStockMember2021-04-012021-06-300001751788us-gaap:TreasuryStockMember2020-04-012020-06-300001751788us-gaap:TreasuryStockMember2021-01-012021-06-300001751788us-gaap:TreasuryStockMember2020-01-012020-06-300001751788us-gaap:TreasuryStockMember2021-06-300001751788us-gaap:TreasuryStockMember2020-06-300001751788dow:TheDowChemicalCompanyMember2021-04-012021-06-300001751788dow:TheDowChemicalCompanyMember2020-04-012020-06-300001751788dow:TheDowChemicalCompanyMember2020-01-012020-06-300001751788dow:TheDowChemicalCompanyMember2020-12-310001751788dow:TheDowChemicalCompanyMember2019-12-310001751788dow:TheDowChemicalCompanyMember2020-06-300001751788us-gaap:CommonStockMemberdow:TheDowChemicalCompanyMember2021-03-310001751788us-gaap:CommonStockMemberdow:TheDowChemicalCompanyMember2021-06-300001751788us-gaap:CommonStockMemberdow:TheDowChemicalCompanyMember2020-03-310001751788us-gaap:CommonStockMemberdow:TheDowChemicalCompanyMember2020-06-300001751788us-gaap:CommonStockMemberdow:TheDowChemicalCompanyMember2020-12-310001751788us-gaap:CommonStockMemberdow:TheDowChemicalCompanyMember2019-12-310001751788dow:TheDowChemicalCompanyMemberus-gaap:AdditionalPaidInCapitalMember2021-03-310001751788dow:TheDowChemicalCompanyMemberus-gaap:AdditionalPaidInCapitalMember2020-03-310001751788dow:TheDowChemicalCompanyMemberus-gaap:AdditionalPaidInCapitalMember2020-12-310001751788dow:TheDowChemicalCompanyMemberus-gaap:AdditionalPaidInCapitalMember2019-12-310001751788dow:TheDowChemicalCompanyMemberus-gaap:AdditionalPaidInCapitalMember2021-04-012021-06-300001751788dow:TheDowChemicalCompanyMemberus-gaap:AdditionalPaidInCapitalMember2020-04-012020-06-300001751788dow:TheDowChemicalCompanyMemberus-gaap:AdditionalPaidInCapitalMember2021-01-012021-06-300001751788dow:TheDowChemicalCompanyMemberus-gaap:AdditionalPaidInCapitalMember2020-01-012020-06-300001751788dow:TheDowChemicalCompanyMemberus-gaap:AdditionalPaidInCapitalMember2021-06-300001751788dow:TheDowChemicalCompanyMemberus-gaap:AdditionalPaidInCapitalMember2020-06-300001751788dow:TheDowChemicalCompanyMemberus-gaap:RetainedEarningsMember2021-03-310001751788dow:TheDowChemicalCompanyMemberus-gaap:RetainedEarningsMember2020-03-310001751788dow:TheDowChemicalCompanyMemberus-gaap:RetainedEarningsMember2020-12-310001751788dow:TheDowChemicalCompanyMemberus-gaap:RetainedEarningsMember2019-12-310001751788dow:TheDowChemicalCompanyMemberus-gaap:RetainedEarningsMember2021-04-012021-06-300001751788dow:TheDowChemicalCompanyMemberus-gaap:RetainedEarningsMember2020-04-012020-06-300001751788dow:TheDowChemicalCompanyMemberus-gaap:RetainedEarningsMember2021-01-012021-06-300001751788dow:TheDowChemicalCompanyMemberus-gaap:RetainedEarningsMember2020-01-012020-06-300001751788dow:DowInc.Memberus-gaap:RetainedEarningsMember2021-04-012021-06-300001751788dow:DowInc.Memberus-gaap:RetainedEarningsMember2020-04-012020-06-300001751788dow:DowInc.Memberus-gaap:RetainedEarningsMember2021-01-012021-06-300001751788dow:DowInc.Memberus-gaap:RetainedEarningsMember2020-01-012020-06-300001751788dow:TheDowChemicalCompanyMemberus-gaap:RetainedEarningsMember2021-06-300001751788dow:TheDowChemicalCompanyMemberus-gaap:RetainedEarningsMember2020-06-300001751788dow:TheDowChemicalCompanyMemberus-gaap:AccumulatedOtherComprehensiveIncomeMember2021-03-310001751788dow:TheDowChemicalCompanyMemberus-gaap:AccumulatedOtherComprehensiveIncomeMember2020-03-310001751788dow:TheDowChemicalCompanyMemberus-gaap:AccumulatedOtherComprehensiveIncomeMember2020-12-310001751788dow:TheDowChemicalCompanyMemberus-gaap:AccumulatedOtherComprehensiveIncomeMember2019-12-310001751788dow:TheDowChemicalCompanyMemberus-gaap:AccumulatedOtherComprehensiveIncomeMember2021-04-012021-06-300001751788dow:TheDowChemicalCompanyMemberus-gaap:AccumulatedOtherComprehensiveIncomeMember2020-04-012020-06-300001751788dow:TheDowChemicalCompanyMemberus-gaap:AccumulatedOtherComprehensiveIncomeMember2021-01-012021-06-300001751788dow:TheDowChemicalCompanyMemberus-gaap:AccumulatedOtherComprehensiveIncomeMember2020-01-012020-06-300001751788dow:TheDowChemicalCompanyMemberus-gaap:AccumulatedOtherComprehensiveIncomeMember2021-06-300001751788dow:TheDowChemicalCompanyMemberus-gaap:AccumulatedOtherComprehensiveIncomeMember2020-06-300001751788dow:TheDowChemicalCompanyMemberdow:UnearnedEsopSharesMember2021-03-310001751788dow:TheDowChemicalCompanyMemberdow:UnearnedEsopSharesMember2020-03-310001751788dow:TheDowChemicalCompanyMemberdow:UnearnedEsopSharesMember2020-12-310001751788dow:TheDowChemicalCompanyMemberdow:UnearnedEsopSharesMember2019-12-310001751788dow:TheDowChemicalCompanyMemberdow:UnearnedEsopSharesMember2021-04-012021-06-300001751788dow:TheDowChemicalCompanyMemberdow:UnearnedEsopSharesMember2020-04-012020-06-300001751788dow:TheDowChemicalCompanyMemberdow:UnearnedEsopSharesMember2021-01-012021-06-300001751788dow:TheDowChemicalCompanyMemberdow:UnearnedEsopSharesMember2020-01-012020-06-300001751788dow:TheDowChemicalCompanyMemberdow:UnearnedEsopSharesMember2021-06-300001751788dow:TheDowChemicalCompanyMemberdow:UnearnedEsopSharesMember2020-06-300001751788dow:TheDowChemicalCompanyMemberus-gaap:NoncontrollingInterestMember2021-06-300001751788dow:TheDowChemicalCompanyMemberus-gaap:NoncontrollingInterestMember2020-06-300001751788us-gaap:OtherCurrentAssetsMember2021-06-300001751788us-gaap:OtherCurrentAssetsMember2020-12-310001751788us-gaap:OtherNoncurrentAssetsMember2021-06-300001751788us-gaap:OtherNoncurrentAssetsMember2020-12-310001751788dow:AccruedAndOtherCurrentLiabilitiesMember2021-06-300001751788dow:AccruedAndOtherCurrentLiabilitiesMember2020-12-310001751788dow:OtherNoncurrentObligationsMember2021-06-300001751788dow:OtherNoncurrentObligationsMember2020-12-31xbrli:pure00017517882021-07-01srt:MaximumMember2021-06-300001751788dow:PackagingSpecialtyPlasticsMemberdow:HydrocarbonsEnergyMember2021-04-012021-06-300001751788dow:PackagingSpecialtyPlasticsMemberdow:HydrocarbonsEnergyMember2020-04-012020-06-300001751788dow:PackagingSpecialtyPlasticsMemberdow:HydrocarbonsEnergyMember2021-01-012021-06-300001751788dow:PackagingSpecialtyPlasticsMemberdow:HydrocarbonsEnergyMember2020-01-012020-06-300001751788dow:PackagingSpecialtyPlasticsMemberdow:PackagingandSpecialtyPlasticsMember2021-04-012021-06-300001751788dow:PackagingSpecialtyPlasticsMemberdow:PackagingandSpecialtyPlasticsMember2020-04-012020-06-300001751788dow:PackagingSpecialtyPlasticsMemberdow:PackagingandSpecialtyPlasticsMember2021-01-012021-06-300001751788dow:PackagingSpecialtyPlasticsMemberdow:PackagingandSpecialtyPlasticsMember2020-01-012020-06-300001751788dow:PackagingSpecialtyPlasticsMember2021-04-012021-06-300001751788dow:PackagingSpecialtyPlasticsMember2020-04-012020-06-300001751788dow:PackagingSpecialtyPlasticsMember2021-01-012021-06-300001751788dow:PackagingSpecialtyPlasticsMember2020-01-012020-06-300001751788dow:IndustrialSolutionsMemberdow:IndustrialIntermediatesInfrastructureMember2021-04-012021-06-300001751788dow:IndustrialSolutionsMemberdow:IndustrialIntermediatesInfrastructureMember2020-04-012020-06-300001751788dow:IndustrialSolutionsMemberdow:IndustrialIntermediatesInfrastructureMember2021-01-012021-06-300001751788dow:IndustrialSolutionsMemberdow:IndustrialIntermediatesInfrastructureMember2020-01-012020-06-300001751788dow:PolyurethanesConstructionChemicalsMemberdow:IndustrialIntermediatesInfrastructureMember2021-04-012021-06-300001751788dow:PolyurethanesConstructionChemicalsMemberdow:IndustrialIntermediatesInfrastructureMember2020-04-012020-06-300001751788dow:PolyurethanesConstructionChemicalsMemberdow:IndustrialIntermediatesInfrastructureMember2021-01-012021-06-300001751788dow:PolyurethanesConstructionChemicalsMemberdow:IndustrialIntermediatesInfrastructureMember2020-01-012020-06-300001751788dow:OtherMemberdow:IndustrialIntermediatesInfrastructureMember2021-04-012021-06-300001751788dow:OtherMemberdow:IndustrialIntermediatesInfrastructureMember2020-04-012020-06-300001751788dow:OtherMemberdow:IndustrialIntermediatesInfrastructureMember2021-01-012021-06-300001751788dow:OtherMemberdow:IndustrialIntermediatesInfrastructureMember2020-01-012020-06-300001751788dow:IndustrialIntermediatesInfrastructureMember2021-04-012021-06-300001751788dow:IndustrialIntermediatesInfrastructureMember2020-04-012020-06-300001751788dow:IndustrialIntermediatesInfrastructureMember2021-01-012021-06-300001751788dow:IndustrialIntermediatesInfrastructureMember2020-01-012020-06-300001751788dow:PerformanceMaterialsCoatingsMemberdow:CoatingsandPerformanceMonomersMember2021-04-012021-06-300001751788dow:PerformanceMaterialsCoatingsMemberdow:CoatingsandPerformanceMonomersMember2020-04-012020-06-300001751788dow:PerformanceMaterialsCoatingsMemberdow:CoatingsandPerformanceMonomersMember2021-01-012021-06-300001751788dow:PerformanceMaterialsCoatingsMemberdow:CoatingsandPerformanceMonomersMember2020-01-012020-06-300001751788dow:PerformanceMaterialsCoatingsMemberdow:ConsumerSolutionsMember2021-04-012021-06-300001751788dow:PerformanceMaterialsCoatingsMemberdow:ConsumerSolutionsMember2020-04-012020-06-300001751788dow:PerformanceMaterialsCoatingsMemberdow:ConsumerSolutionsMember2021-01-012021-06-300001751788dow:PerformanceMaterialsCoatingsMemberdow:ConsumerSolutionsMember2020-01-012020-06-300001751788dow:PerformanceMaterialsCoatingsMember2021-04-012021-06-300001751788dow:PerformanceMaterialsCoatingsMember2020-04-012020-06-300001751788dow:PerformanceMaterialsCoatingsMember2021-01-012021-06-300001751788dow:PerformanceMaterialsCoatingsMember2020-01-012020-06-300001751788us-gaap:CorporateMember2021-04-012021-06-300001751788us-gaap:CorporateMember2020-04-012020-06-300001751788us-gaap:CorporateMember2021-01-012021-06-300001751788us-gaap:CorporateMember2020-01-012020-06-300001751788dow:U.S.CanadaMember2021-04-012021-06-300001751788dow:U.S.CanadaMember2020-04-012020-06-300001751788dow:U.S.CanadaMember2021-01-012021-06-300001751788dow:U.S.CanadaMember2020-01-012020-06-300001751788dow:EuropeMiddleEastAfricaandIndiaDomain2021-04-012021-06-300001751788dow:EuropeMiddleEastAfricaandIndiaDomain2020-04-012020-06-300001751788dow:EuropeMiddleEastAfricaandIndiaDomain2021-01-012021-06-300001751788dow:EuropeMiddleEastAfricaandIndiaDomain2020-01-012020-06-300001751788srt:AsiaPacificMember2021-04-012021-06-300001751788srt:AsiaPacificMember2020-04-012020-06-300001751788srt:AsiaPacificMember2021-01-012021-06-300001751788srt:AsiaPacificMember2020-01-012020-06-300001751788srt:LatinAmericaMember2021-04-012021-06-300001751788srt:LatinAmericaMember2020-04-012020-06-300001751788srt:LatinAmericaMember2021-01-012021-06-300001751788srt:LatinAmericaMember2020-01-012020-06-300001751788dow:A2020RestructuringProgramMember2021-01-012021-06-300001751788dow:A2020RestructuringProgramMember2021-04-012021-06-300001751788dow:A2020RestructuringProgramMemberdow:TheDowChemicalCompanyMember2021-06-300001751788dow:A2020RestructuringProgramMemberdow:AssetwritedownsandwriteoffsMember2021-04-012021-06-300001751788dow:A2020RestructuringProgramMemberdow:CostsAssociatedwithExitandDisposalActivitiesMember2021-04-012021-06-300001751788dow:PackagingSpecialtyPlasticsMemberdow:A2020RestructuringProgramMemberus-gaap:EmployeeSeveranceMember2020-07-012020-09-300001751788dow:PackagingSpecialtyPlasticsMemberdow:A2020RestructuringProgramMemberdow:AssetwritedownsandwriteoffsMember2020-07-012020-09-300001751788dow:PackagingSpecialtyPlasticsMemberdow:A2020RestructuringProgramMemberdow:CostsAssociatedwithExitandDisposalActivitiesMember2020-07-012020-09-300001751788dow:PackagingSpecialtyPlasticsMemberdow:A2020RestructuringProgramMember2020-07-012020-09-300001751788dow:A2020RestructuringProgramMemberdow:IndustrialIntermediatesInfrastructureMemberus-gaap:EmployeeSeveranceMember2020-07-012020-09-300001751788dow:A2020RestructuringProgramMemberdow:IndustrialIntermediatesInfrastructureMemberdow:AssetwritedownsandwriteoffsMember2020-07-012020-09-300001751788dow:A2020RestructuringProgramMemberdow:IndustrialIntermediatesInfrastructureMemberdow:CostsAssociatedwithExitandDisposalActivitiesMember2020-07-012020-09-300001751788dow:A2020RestructuringProgramMemberdow:IndustrialIntermediatesInfrastructureMember2020-07-012020-09-300001751788dow:A2020RestructuringProgramMemberus-gaap:EmployeeSeveranceMemberdow:PerformanceMaterialsCoatingsMember2020-07-012020-09-300001751788dow:A2020RestructuringProgramMemberdow:PerformanceMaterialsCoatingsMemberdow:AssetwritedownsandwriteoffsMember2020-07-012020-09-300001751788dow:A2020RestructuringProgramMemberdow:PerformanceMaterialsCoatingsMemberdow:CostsAssociatedwithExitandDisposalActivitiesMember2020-07-012020-09-300001751788dow:A2020RestructuringProgramMemberdow:PerformanceMaterialsCoatingsMember2020-07-012020-09-300001751788dow:A2020RestructuringProgramMemberus-gaap:CorporateMemberus-gaap:EmployeeSeveranceMember2020-07-012020-09-300001751788dow:A2020RestructuringProgramMemberus-gaap:CorporateMemberdow:AssetwritedownsandwriteoffsMember2020-07-012020-09-300001751788dow:A2020RestructuringProgramMemberus-gaap:CorporateMemberdow:CostsAssociatedwithExitandDisposalActivitiesMember2020-07-012020-09-300001751788dow:A2020RestructuringProgramMemberus-gaap:CorporateMember2020-07-012020-09-300001751788dow:A2020RestructuringProgramMemberus-gaap:EmployeeSeveranceMember2020-07-012020-09-300001751788dow:A2020RestructuringProgramMemberdow:AssetwritedownsandwriteoffsMember2020-07-012020-09-300001751788dow:A2020RestructuringProgramMemberdow:CostsAssociatedwithExitandDisposalActivitiesMember2020-07-012020-09-300001751788dow:A2020RestructuringProgramMember2020-07-012020-09-300001751788dow:A2020RestructuringProgramMemberus-gaap:EmployeeSeveranceMember2020-09-300001751788dow:A2020RestructuringProgramMemberdow:AssetwritedownsandwriteoffsMember2020-09-300001751788dow:A2020RestructuringProgramMemberdow:CostsAssociatedwithExitandDisposalActivitiesMember2020-09-300001751788dow:A2020RestructuringProgramMember2020-09-300001751788dow:A2020RestructuringProgramMemberus-gaap:EmployeeSeveranceMemberdow:PerformanceMaterialsCoatingsMember2020-10-012020-12-310001751788dow:A2020RestructuringProgramMemberdow:PerformanceMaterialsCoatingsMemberdow:AssetwritedownsandwriteoffsMember2020-10-012020-12-310001751788dow:A2020RestructuringProgramMemberdow:PerformanceMaterialsCoatingsMemberdow:CostsAssociatedwithExitandDisposalActivitiesMember2020-10-012020-12-310001751788dow:A2020RestructuringProgramMemberdow:PerformanceMaterialsCoatingsMember2020-10-012020-12-310001751788dow:A2020RestructuringProgramMemberus-gaap:CorporateMemberus-gaap:EmployeeSeveranceMember2020-10-012020-12-310001751788dow:A2020RestructuringProgramMemberus-gaap:CorporateMemberdow:AssetwritedownsandwriteoffsMember2020-10-012020-12-310001751788dow:A2020RestructuringProgramMemberus-gaap:CorporateMemberdow:CostsAssociatedwithExitandDisposalActivitiesMember2020-10-012020-12-310001751788dow:A2020RestructuringProgramMemberus-gaap:CorporateMember2020-10-012020-12-310001751788dow:A2020RestructuringProgramMemberus-gaap:EmployeeSeveranceMember2020-10-012020-12-310001751788dow:A2020RestructuringProgramMemberdow:AssetwritedownsandwriteoffsMember2020-10-012020-12-310001751788dow:A2020RestructuringProgramMemberdow:CostsAssociatedwithExitandDisposalActivitiesMember2020-10-012020-12-310001751788dow:A2020RestructuringProgramMember2020-10-012020-12-310001751788dow:A2020RestructuringProgramMemberus-gaap:EmployeeSeveranceMember2020-12-310001751788dow:A2020RestructuringProgramMemberdow:AssetwritedownsandwriteoffsMember2020-12-310001751788dow:A2020RestructuringProgramMemberdow:CostsAssociatedwithExitandDisposalActivitiesMember2020-12-310001751788dow:A2020RestructuringProgramMember2020-12-310001751788dow:A2020RestructuringProgramMemberus-gaap:EmployeeSeveranceMember2021-01-012021-03-310001751788dow:A2020RestructuringProgramMemberdow:AssetwritedownsandwriteoffsMember2021-01-012021-03-310001751788dow:A2020RestructuringProgramMemberdow:CostsAssociatedwithExitandDisposalActivitiesMember2021-01-012021-03-310001751788dow:A2020RestructuringProgramMember2021-01-012021-03-310001751788dow:A2020RestructuringProgramMemberus-gaap:EmployeeSeveranceMember2021-03-310001751788dow:A2020RestructuringProgramMemberdow:AssetwritedownsandwriteoffsMember2021-03-310001751788dow:A2020RestructuringProgramMemberdow:CostsAssociatedwithExitandDisposalActivitiesMember2021-03-310001751788dow:A2020RestructuringProgramMember2021-03-310001751788dow:PackagingSpecialtyPlasticsMemberdow:A2020RestructuringProgramMemberus-gaap:EmployeeSeveranceMember2021-04-012021-06-300001751788dow:PackagingSpecialtyPlasticsMemberdow:A2020RestructuringProgramMemberdow:AssetwritedownsandwriteoffsMember2021-04-012021-06-300001751788dow:PackagingSpecialtyPlasticsMemberdow:A2020RestructuringProgramMemberdow:CostsAssociatedwithExitandDisposalActivitiesMember2021-04-012021-06-300001751788dow:PackagingSpecialtyPlasticsMemberdow:A2020RestructuringProgramMember2021-04-012021-06-300001751788dow:A2020RestructuringProgramMemberdow:IndustrialIntermediatesInfrastructureMemberus-gaap:EmployeeSeveranceMember2021-04-012021-06-300001751788dow:A2020RestructuringProgramMemberdow:IndustrialIntermediatesInfrastructureMemberdow:AssetwritedownsandwriteoffsMember2021-04-012021-06-300001751788dow:A2020RestructuringProgramMemberdow:IndustrialIntermediatesInfrastructureMemberdow:CostsAssociatedwithExitandDisposalActivitiesMember2021-04-012021-06-300001751788dow:A2020RestructuringProgramMemberdow:IndustrialIntermediatesInfrastructureMember2021-04-012021-06-300001751788dow:A2020RestructuringProgramMemberus-gaap:EmployeeSeveranceMemberdow:PerformanceMaterialsCoatingsMember2021-04-012021-06-300001751788dow:A2020RestructuringProgramMemberdow:PerformanceMaterialsCoatingsMemberdow:AssetwritedownsandwriteoffsMember2021-04-012021-06-300001751788dow:A2020RestructuringProgramMemberdow:PerformanceMaterialsCoatingsMemberdow:CostsAssociatedwithExitandDisposalActivitiesMember2021-04-012021-06-300001751788dow:A2020RestructuringProgramMemberdow:PerformanceMaterialsCoatingsMember2021-04-012021-06-300001751788dow:A2020RestructuringProgramMemberus-gaap:CorporateMemberus-gaap:EmployeeSeveranceMember2021-04-012021-06-300001751788dow:A2020RestructuringProgramMemberus-gaap:CorporateMemberdow:AssetwritedownsandwriteoffsMember2021-04-012021-06-300001751788dow:A2020RestructuringProgramMemberus-gaap:CorporateMemberdow:CostsAssociatedwithExitandDisposalActivitiesMember2021-04-012021-06-300001751788dow:A2020RestructuringProgramMemberus-gaap:CorporateMember2021-04-012021-06-300001751788dow:A2020RestructuringProgramMemberus-gaap:EmployeeSeveranceMember2021-04-012021-06-300001751788dow:A2020RestructuringProgramMemberus-gaap:EmployeeSeveranceMember2021-06-300001751788dow:A2020RestructuringProgramMemberdow:AssetwritedownsandwriteoffsMember2021-06-300001751788dow:A2020RestructuringProgramMemberdow:CostsAssociatedwithExitandDisposalActivitiesMember2021-06-300001751788dow:A2020RestructuringProgramMember2021-06-300001751788dow:A2020RestructuringProgramMemberdow:AccruedAndOtherCurrentLiabilitiesMember2021-06-300001751788dow:A2020RestructuringProgramMemberdow:AccruedAndOtherCurrentLiabilitiesMember2020-12-310001751788dow:A2020RestructuringProgramMemberdow:OtherNoncurrentObligationsMember2021-06-300001751788dow:A2020RestructuringProgramMemberdow:OtherNoncurrentObligationsMember2020-12-310001751788dow:A2020RestructuringProgramMember2020-09-012021-06-300001751788dow:A2020RestructuringProgramMemberus-gaap:EmployeeSeveranceMember2020-09-012021-06-300001751788dow:A2020RestructuringProgramMemberdow:AssetwritedownsandwriteoffsMember2020-09-012021-06-300001751788dow:A2020RestructuringProgramMemberdow:CostsAssociatedwithExitandDisposalActivitiesMember2020-09-012021-06-300001751788us-gaap:NonoperatingIncomeExpenseMember2021-04-012021-06-300001751788us-gaap:NonoperatingIncomeExpenseMember2020-04-012020-06-300001751788us-gaap:NonoperatingIncomeExpenseMember2021-01-012021-06-300001751788us-gaap:NonoperatingIncomeExpenseMember2020-01-012020-06-300001751788dow:DowV.NovaChemicalsCorporationEthyleneAssetMatterMemberMemberus-gaap:NonoperatingIncomeExpenseMember2021-04-012021-06-300001751788dow:DowV.NovaChemicalsCorporationEthyleneAssetMatterMemberMemberus-gaap:NonoperatingIncomeExpenseMember2020-04-012020-06-300001751788dow:DowV.NovaChemicalsCorporationEthyleneAssetMatterMemberMemberus-gaap:NonoperatingIncomeExpenseMember2021-01-012021-06-300001751788dow:DowV.NovaChemicalsCorporationEthyleneAssetMatterMemberMemberus-gaap:NonoperatingIncomeExpenseMember2020-01-012020-06-300001751788dow:DowV.NovaChemicalsCorporationEthyleneAssetMatterMemberMemberdow:TheDowChemicalCompanyMember2021-04-012021-06-300001751788dow:DowV.NovaChemicalsCorporationEthyleneAssetMatterMemberMemberdow:TheDowChemicalCompanyMember2020-04-012020-06-300001751788dow:DowV.NovaChemicalsCorporationEthyleneAssetMatterMemberMemberdow:TheDowChemicalCompanyMember2021-01-012021-06-300001751788dow:DowV.NovaChemicalsCorporationEthyleneAssetMatterMemberMemberdow:TheDowChemicalCompanyMember2020-01-012020-06-300001751788dow:EQUATEPetrochemicalCompanyKscAndTheKuwaitOlefinsCompanyKSCCMember2020-06-300001751788dow:EquatePetrochemicalCompanyKscMember2021-06-300001751788dow:EquatePetrochemicalCompanyKscMember2020-12-310001751788dow:SadaraChemicalCompanyMember2021-06-300001751788dow:SadaraChemicalCompanyMember2020-12-310001751788dow:PackagingSpecialtyPlasticsMember2020-12-310001751788dow:IndustrialIntermediatesInfrastructureMember2020-12-310001751788dow:PerformanceMaterialsCoatingsMember2020-12-310001751788dow:PackagingSpecialtyPlasticsMember2021-06-300001751788dow:IndustrialIntermediatesInfrastructureMember2021-06-300001751788dow:PerformanceMaterialsCoatingsMember2021-06-300001751788us-gaap:DevelopedTechnologyRightsMember2021-06-300001751788us-gaap:DevelopedTechnologyRightsMember2020-12-310001751788us-gaap:ComputerSoftwareIntangibleAssetMember2021-06-300001751788us-gaap:ComputerSoftwareIntangibleAssetMember2020-12-310001751788us-gaap:TrademarksAndTradeNamesMember2021-06-300001751788us-gaap:TrademarksAndTradeNamesMember2020-12-310001751788us-gaap:CustomerRelatedIntangibleAssetsMember2021-06-300001751788us-gaap:CustomerRelatedIntangibleAssetsMember2020-12-310001751788us-gaap:OtherIntangibleAssetsMember2021-04-012021-06-300001751788us-gaap:OtherIntangibleAssetsMember2020-04-012020-06-300001751788us-gaap:OtherIntangibleAssetsMember2021-01-012021-06-300001751788us-gaap:OtherIntangibleAssetsMember2020-01-012020-06-300001751788us-gaap:ComputerSoftwareIntangibleAssetMember2021-04-012021-06-300001751788us-gaap:ComputerSoftwareIntangibleAssetMember2020-04-012020-06-300001751788us-gaap:ComputerSoftwareIntangibleAssetMember2021-01-012021-06-300001751788us-gaap:ComputerSoftwareIntangibleAssetMember2020-01-012020-06-300001751788us-gaap:NotesPayableToBanksMember2021-06-300001751788us-gaap:NotesPayableToBanksMember2020-12-310001751788us-gaap:LoansPayableMemberdow:PromissoryNotesandDebenturesFinalMaturityCurrentYearMember2021-06-300001751788us-gaap:LoansPayableMemberdow:PromissoryNotesandDebenturesFinalMaturityCurrentYearMember2020-12-310001751788dow:PromissoryNotesandDebenturesFinalMaturityYearOneMemberus-gaap:LoansPayableMember2021-06-300001751788dow:PromissoryNotesandDebenturesFinalMaturityYearOneMemberus-gaap:LoansPayableMember2020-12-310001751788dow:PromissoryNotesandDebenturesFinalMaturityYearTwoMemberus-gaap:LoansPayableMember2021-06-300001751788dow:PromissoryNotesandDebenturesFinalMaturityYearTwoMemberus-gaap:LoansPayableMember2020-12-310001751788dow:PromissoryNotesandDebenturesFinalMaturityYearThreeMemberus-gaap:LoansPayableMember2021-06-300001751788dow:PromissoryNotesandDebenturesFinalMaturityYearThreeMemberus-gaap:LoansPayableMember2020-12-310001751788dow:PromissoryNotesandDebenturesFinalMaturityYearFourMemberus-gaap:LoansPayableMember2021-06-300001751788dow:PromissoryNotesandDebenturesFinalMaturityYearFourMemberus-gaap:LoansPayableMember2020-12-310001751788dow:PromissoryNotesandDebenturesFinalMaturityYearFiveMemberus-gaap:LoansPayableMember2021-06-300001751788dow:PromissoryNotesandDebenturesFinalMaturityYearFiveMemberus-gaap:LoansPayableMember2020-12-310001751788us-gaap:LoansPayableMemberdow:PromissoryNotesandDebenturesFinalMaturityYearSixandThereafterMember2021-06-300001751788us-gaap:LoansPayableMemberdow:PromissoryNotesandDebenturesFinalMaturityYearSixandThereafterMember2020-12-310001751788us-gaap:LoansPayableMemberdow:ForeignCurrencyLoansMember2021-06-300001751788us-gaap:LoansPayableMemberdow:ForeignCurrencyLoansMember2020-12-310001751788us-gaap:MediumTermNotesMember2021-06-300001751788us-gaap:MediumTermNotesMember2020-12-310001751788dow:FinanceLeasesMember2021-06-300001751788dow:FinanceLeasesMember2020-12-310001751788dow:ThreePointOneFivePercentNotesDue2024Member2021-04-012021-06-300001751788dow:ThreePointOneFivePercentNotesDue2024Member2021-06-300001751788dow:ThreePointFivePercentNotesDue2024Member2021-04-012021-06-300001751788dow:ThreePointFivePercentNotesDue2024Member2021-06-300001751788dow:A315PercentNotesDue2024And350PercentNotesDue2024Memberdow:SundryIncomeExpenseNetMember2021-04-012021-06-300001751788dow:InterNotesredeemedMember2021-01-012021-06-300001751788dow:InterNotesRedeemedVariousMaturitiesMember2021-01-012021-06-300001751788dow:InterNotesRedeemedVariousMaturitiesMemberdow:SundryIncomeExpenseNetMember2021-04-012021-06-300001751788dow:InterNotesRedeemedVariousMaturitiesMemberdow:SundryIncomeExpenseNetMember2021-01-012021-06-300001751788dow:LongTermDebtRepaymentVariableInterestEntityMember2021-01-012021-06-30iso4217:EUR0001751788dow:EurosNotesMember2020-02-010001751788dow:A050PercentNotesDue2027Member2020-02-010001751788dow:A1125PercentNotesDue2032Member2020-02-010001751788dow:A1875PercentNotesDue2040Member2020-02-010001751788dow:TermLoanFacilityDueSeptember2023Memberus-gaap:RevolvingCreditFacilityMember2020-01-012020-03-310001751788dow:A30PercentNotesDue2022Member2020-01-012020-03-310001751788dow:A30PercentNotesDue2022Member2020-03-310001751788dow:SundryIncomeExpenseNetMemberdow:A30PercentNotesDue2022Member2020-01-012020-03-310001751788dow:InterNotesredeemedMember2020-01-012020-06-300001751788dow:InterNotesRedeemedVariousMaturitiesMember2020-01-012020-06-300001751788dow:InterNotesRedeemedVariousMaturitiesMemberdow:SundryIncomeExpenseNetMember2020-01-012020-06-300001751788dow:LongTermDebtRepaymentVariableInterestEntityMember2020-01-012020-06-300001751788dow:FiveYearCompetitiveAdvanceandRevolvingCreditFacilityMemberus-gaap:RevolvingCreditFacilityMember2021-06-300001751788dow:BilateralRevolvingCreditFacilityDueDecember2021FacilityOneMemberus-gaap:RevolvingCreditFacilityMember2021-06-300001751788dow:BilateralRevolvingCreditFacilityDueDecember2021FacilityTwoMemberus-gaap:RevolvingCreditFacilityMember2021-06-300001751788dow:BilateralRevolvingCreditFacilityDueMarch2022Memberus-gaap:RevolvingCreditFacilityMember2021-06-300001751788dow:BilateralRevolvingCreditFacilityDueJune2022Memberus-gaap:RevolvingCreditFacilityMember2021-06-300001751788dow:BilateralRevolvingCreditFacilityDueSeptember2022Memberus-gaap:RevolvingCreditFacilityMember2021-06-300001751788dow:BilateralRevolvingCreditFacilityDueNovember2022Memberus-gaap:RevolvingCreditFacilityMember2021-06-300001751788us-gaap:RevolvingCreditFacilityMemberdow:BilateralRevolvingCreditFacilityDueSeptember2023FacilityOneMember2021-06-300001751788us-gaap:RevolvingCreditFacilityMemberdow:BilateralRevolvingCreditFacilityDueSeptember2023FacilityTwoMember2021-06-300001751788us-gaap:RevolvingCreditFacilityMemberdow:BilateralRevolvingCreditFacilityDueSeptember2023FacilityThreeMember2021-06-300001751788us-gaap:RevolvingCreditFacilityMemberdow:BilateralRevolvingCreditFacilityDueOctober2024FacilityOneMember2021-06-300001751788dow:BilateralRevolvingCreditFacilityDueOctober2024FacilityTwoMemberus-gaap:RevolvingCreditFacilityMember2021-06-300001751788dow:BilateralRevolvingCreditFacilityDueNovember2024Memberus-gaap:RevolvingCreditFacilityMember2021-06-300001751788dow:BilateralRevolvingCreditFacilityDueMarch2025FacilityOneMemberus-gaap:RevolvingCreditFacilityMember2021-06-300001751788us-gaap:RevolvingCreditFacilityMemberdow:BilateralRevolvingCreditFacilityDueMarch2025FacilityTwoMember2021-06-300001751788dow:BilateralRevolvingCreditFacilityDueMarch2025FacilityThreeMemberus-gaap:RevolvingCreditFacilityMember2021-06-300001751788dow:AccrualForEnvironmentalLossContingenciesSuperFundSitesMember2021-06-300001751788dow:AccrualForEnvironmentalLossContingenciesSuperFundSitesMember2020-12-310001751788dow:DowSiliconesCorporationMemberdow:BreastImplantandOtherProductsLiabilityClaimsMember2021-06-300001751788dow:DowSiliconesCorporationMemberdow:BreastImplantandOtherProductsLiabilityClaimsMember2020-12-310001751788dow:DowSiliconesCorporationMemberdow:BreastImplantandOtherProductsLiabilityClaimsMemberdow:AccruedAndOtherCurrentLiabilitiesMember2021-06-300001751788dow:DowSiliconesCorporationMemberdow:BreastImplantandOtherProductsLiabilityClaimsMemberdow:AccruedAndOtherCurrentLiabilitiesMember2020-12-310001751788dow:DowSiliconesCorporationMemberdow:OtherNoncurrentObligationsMemberdow:BreastImplantandOtherProductsLiabilityClaimsMember2021-06-300001751788dow:DowSiliconesCorporationMemberdow:OtherNoncurrentObligationsMemberdow:BreastImplantandOtherProductsLiabilityClaimsMember2020-12-310001751788dow:DowSiliconesCorporationMemberus-gaap:OtherNoncurrentAssetsMember2021-06-300001751788dow:DowSiliconesCorporationMemberus-gaap:OtherNoncurrentAssetsMember2020-12-31iso4217:CAD0001751788dow:DowV.NovaChemicalsCorporationPatentInfringementMatterMember2017-06-292017-06-290001751788dow:DowV.NovaChemicalsCorporationPatentInfringementMatterMember2017-07-062017-07-060001751788dow:DowV.NovaChemicalsCorporationPatentInfringementMatterMember2021-06-300001751788dow:DowV.NovaChemicalsCorporationPatentInfringementMatterMember2020-12-310001751788dow:DowV.NovaChemicalsCorporationEthyleneAssetMatterMemberMember2019-09-182019-09-180001751788dow:DowV.NovaChemicalsCorporationEthyleneAssetMatterMemberMember2019-10-112019-10-110001751788dow:DowV.NovaChemicalsCorporationEthyleneAssetMatterMemberMember2019-10-012019-10-240001751788dow:DowV.NovaChemicalsCorporationEthyleneAssetMatterMemberMember2020-03-312020-03-310001751788dow:DowV.NovaChemicalsCorporationEthyleneAssetMatterMemberMember2021-06-300001751788dow:DowV.NovaChemicalsCorporationEthyleneAssetMatterMemberMember2020-12-310001751788dow:DowVBrazilExcessPISCOFINSTaxesMemberus-gaap:CostOfSalesMember2021-04-012021-06-300001751788dow:DowVBrazilExcessPISCOFINSTaxesMember2021-06-300001751788us-gaap:PerformanceGuaranteeMember2021-06-300001751788us-gaap:PerformanceGuaranteeMember2020-12-310001751788dow:TotalProjectFinancingMemberdow:SadaraChemicalCompanyMember2021-06-300001751788us-gaap:PerformanceGuaranteeMemberdow:SadaraChemicalCompanyMember2021-06-300001751788us-gaap:PerformanceGuaranteeMemberdow:SadaraChemicalCompanyMember2020-12-310001751788us-gaap:PerformanceGuaranteeMemberdow:SadaraChemicalCompanyMemberdow:SadaraChemicalCompanyMember2021-06-3000017517882020-01-012020-12-310001751788dow:FinanceLeasesMember2021-06-300001751788dow:FinanceLeasesMember2020-12-310001751788dow:ResidualValueGuaranteesMember2021-06-300001751788dow:ResidualValueGuaranteesMember2020-12-310001751788dow:ResidualValueGuaranteesMember2021-01-012021-06-300001751788us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2021-03-310001751788us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2020-03-310001751788us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2020-12-310001751788us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2019-12-310001751788us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2021-04-012021-06-300001751788us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2020-04-012020-06-300001751788us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2021-01-012021-06-300001751788us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2020-01-012020-06-300001751788us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2021-04-012021-06-300001751788us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2020-04-012020-06-300001751788us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2021-01-012021-06-300001751788us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2020-01-012020-06-300001751788us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2021-06-300001751788us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2020-06-300001751788us-gaap:AccumulatedTranslationAdjustmentMember2021-03-310001751788us-gaap:AccumulatedTranslationAdjustmentMember2020-03-310001751788us-gaap:AccumulatedTranslationAdjustmentMember2020-12-310001751788us-gaap:AccumulatedTranslationAdjustmentMember2019-12-310001751788us-gaap:AccumulatedTranslationAdjustmentMember2021-04-012021-06-300001751788us-gaap:AccumulatedTranslationAdjustmentMember2020-04-012020-06-300001751788us-gaap:AccumulatedTranslationAdjustmentMember2021-01-012021-06-300001751788us-gaap:AccumulatedTranslationAdjustmentMember2020-01-012020-06-300001751788us-gaap:AccumulatedTranslationAdjustmentMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2021-04-012021-06-300001751788us-gaap:AccumulatedTranslationAdjustmentMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2020-04-012020-06-300001751788us-gaap:AccumulatedTranslationAdjustmentMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2021-01-012021-06-300001751788us-gaap:AccumulatedTranslationAdjustmentMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2020-01-012020-06-300001751788us-gaap:AccumulatedTranslationAdjustmentMember2021-06-300001751788us-gaap:AccumulatedTranslationAdjustmentMember2020-06-300001751788us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2021-03-310001751788us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2020-03-310001751788us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2020-12-310001751788us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2019-12-310001751788us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2021-04-012021-06-300001751788us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2020-04-012020-06-300001751788us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2021-01-012021-06-300001751788us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2020-01-012020-06-300001751788us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2021-06-300001751788us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2020-06-300001751788us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2021-03-310001751788us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2020-03-310001751788us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2020-12-310001751788us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2019-12-310001751788us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2021-04-012021-06-300001751788us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2020-04-012020-06-300001751788us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2021-01-012021-06-300001751788us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2020-01-012020-06-300001751788us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2021-06-300001751788us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2020-06-300001751788us-gaap:NoncontrollingInterestMember2021-03-310001751788us-gaap:NoncontrollingInterestMember2020-03-310001751788us-gaap:NoncontrollingInterestMember2020-12-310001751788us-gaap:NoncontrollingInterestMember2019-12-310001751788us-gaap:NoncontrollingInterestMember2021-04-012021-06-300001751788us-gaap:NoncontrollingInterestMember2020-04-012020-06-300001751788us-gaap:NoncontrollingInterestMember2021-01-012021-06-300001751788us-gaap:NoncontrollingInterestMember2020-01-012020-06-300001751788us-gaap:NoncontrollingInterestMember2021-06-300001751788us-gaap:NoncontrollingInterestMember2020-06-300001751788dow:AutomaticNonElectiveContributionMember2021-01-012021-06-300001751788country:US2021-01-012021-06-300001751788us-gaap:PensionPlansDefinedBenefitMember2021-06-300001751788us-gaap:PensionPlansDefinedBenefitMember2021-01-012021-06-300001751788country:US2021-01-012021-02-280001751788us-gaap:PensionPlansDefinedBenefitMember2021-04-012021-06-300001751788us-gaap:PensionPlansDefinedBenefitMember2020-04-012020-06-300001751788us-gaap:PensionPlansDefinedBenefitMember2020-01-012020-06-300001751788us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2021-04-012021-06-300001751788us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2020-04-012020-06-300001751788us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2021-01-012021-06-300001751788us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2020-01-012020-06-3000017517882021-01-012021-03-310001751788us-gaap:RestrictedStockUnitsRSUMember2021-01-012021-03-310001751788dow:PerformanceStockUnitsPSUsMember2021-01-012021-03-310001751788dow:EmployeeStockPurchasePlanMember2021-06-300001751788dow:EmployeeStockPurchasePlanMember2021-06-012021-06-300001751788dow:EmployeeStockPurchasePlanMemberdow:EmployeeMember2021-04-012021-06-300001751788us-gaap:HeldtomaturitySecuritiesMember2021-06-300001751788us-gaap:HeldtomaturitySecuritiesMember2020-12-310001751788us-gaap:MoneyMarketFundsMember2021-06-300001751788us-gaap:MoneyMarketFundsMember2020-12-310001751788us-gaap:USTreasuryAndGovernmentMember2021-06-300001751788us-gaap:USTreasuryAndGovernmentMember2020-12-310001751788us-gaap:CorporateDebtSecuritiesMember2021-06-300001751788us-gaap:CorporateDebtSecuritiesMember2020-12-310001751788us-gaap:InterestRateContractMember2021-06-300001751788us-gaap:InterestRateContractMember2020-12-310001751788us-gaap:ForeignExchangeContractMember2021-06-300001751788us-gaap:ForeignExchangeContractMember2020-12-310001751788us-gaap:CommodityContractMember2021-06-300001751788us-gaap:CommodityContractMember2020-12-310001751788us-gaap:InterestRateSwapMemberus-gaap:DesignatedAsHedgingInstrumentMember2021-06-300001751788us-gaap:InterestRateSwapMemberus-gaap:DesignatedAsHedgingInstrumentMember2020-12-310001751788us-gaap:ForeignExchangeContractMemberus-gaap:DesignatedAsHedgingInstrumentMember2021-06-300001751788us-gaap:ForeignExchangeContractMemberus-gaap:DesignatedAsHedgingInstrumentMember2020-12-310001751788us-gaap:InterestRateSwapMemberus-gaap:NondesignatedMember2021-06-300001751788us-gaap:InterestRateSwapMemberus-gaap:NondesignatedMember2020-12-310001751788us-gaap:NondesignatedMemberus-gaap:ForeignExchangeContractMember2021-06-300001751788us-gaap:NondesignatedMemberus-gaap:ForeignExchangeContractMember2020-12-31utr:Boe0001751788us-gaap:DesignatedAsHedgingInstrumentMemberdow:CommodityContractHydrocarbonsMember2021-06-300001751788us-gaap:DesignatedAsHedgingInstrumentMemberdow:CommodityContractHydrocarbonsMember2020-12-310001751788us-gaap:NondesignatedMemberdow:CommodityContractHydrocarbonsMember2021-06-300001751788us-gaap:NondesignatedMemberdow:CommodityContractHydrocarbonsMember2020-12-310001751788us-gaap:InterestRateContractMemberus-gaap:OtherCurrentAssetsMemberus-gaap:FairValueInputsLevel2Memberus-gaap:DesignatedAsHedgingInstrumentMember2021-06-300001751788us-gaap:ForeignExchangeContractMemberus-gaap:OtherCurrentAssetsMemberus-gaap:FairValueInputsLevel2Memberus-gaap:DesignatedAsHedgingInstrumentMember2021-06-300001751788us-gaap:CommodityContractMemberus-gaap:OtherCurrentAssetsMemberus-gaap:FairValueInputsLevel2Memberus-gaap:DesignatedAsHedgingInstrumentMember2021-06-300001751788us-gaap:CommodityContractMemberdow:DeferredchargesandotherassetsMemberus-gaap:FairValueInputsLevel2Memberus-gaap:DesignatedAsHedgingInstrumentMember2021-06-300001751788us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueInputsLevel2Member2021-06-300001751788us-gaap:InterestRateContractMemberus-gaap:NondesignatedMemberdow:DeferredchargesandotherassetsMemberus-gaap:FairValueInputsLevel2Member2021-06-300001751788us-gaap:NondesignatedMemberus-gaap:ForeignExchangeContractMemberus-gaap:OtherCurrentAssetsMemberus-gaap:FairValueInputsLevel2Member2021-06-300001751788us-gaap:NondesignatedMemberus-gaap:CommodityContractMemberus-gaap:OtherCurrentAssetsMemberus-gaap:FairValueInputsLevel2Member2021-06-300001751788us-gaap:NondesignatedMemberus-gaap:FairValueInputsLevel2Member2021-06-300001751788us-gaap:FairValueInputsLevel2Member2021-06-300001751788us-gaap:InterestRateContractMemberdow:OtherNoncurrentObligationsMemberus-gaap:FairValueInputsLevel2Memberus-gaap:DesignatedAsHedgingInstrumentMember2021-06-300001751788us-gaap:ForeignExchangeContractMemberus-gaap:FairValueInputsLevel2Memberus-gaap:DesignatedAsHedgingInstrumentMemberdow:AccruedAndOtherCurrentLiabilitiesMember2021-06-300001751788us-gaap:CommodityContractMemberus-gaap:FairValueInputsLevel2Memberus-gaap:DesignatedAsHedgingInstrumentMemberdow:AccruedAndOtherCurrentLiabilitiesMember2021-06-300001751788us-gaap:CommodityContractMemberdow:OtherNoncurrentObligationsMemberus-gaap:FairValueInputsLevel2Memberus-gaap:DesignatedAsHedgingInstrumentMember2021-06-300001751788us-gaap:InterestRateContractMemberus-gaap:NondesignatedMemberdow:OtherNoncurrentObligationsMemberus-gaap:FairValueInputsLevel2Member2021-06-300001751788us-gaap:NondesignatedMemberus-gaap:ForeignExchangeContractMemberus-gaap:FairValueInputsLevel2Memberdow:AccruedAndOtherCurrentLiabilitiesMember2021-06-300001751788us-gaap:NondesignatedMemberus-gaap:CommodityContractMemberus-gaap:FairValueInputsLevel2Memberdow:AccruedAndOtherCurrentLiabilitiesMember2021-06-300001751788us-gaap:InterestRateContractMemberus-gaap:OtherCurrentAssetsMemberus-gaap:FairValueInputsLevel2Memberus-gaap:DesignatedAsHedgingInstrumentMember2020-12-310001751788us-gaap:ForeignExchangeContractMemberus-gaap:OtherCurrentAssetsMemberus-gaap:FairValueInputsLevel2Memberus-gaap:DesignatedAsHedgingInstrumentMember2020-12-310001751788us-gaap:CommodityContractMemberus-gaap:OtherCurrentAssetsMemberus-gaap:FairValueInputsLevel2Memberus-gaap:DesignatedAsHedgingInstrumentMember2020-12-310001751788us-gaap:CommodityContractMemberdow:DeferredchargesandotherassetsMemberus-gaap:FairValueInputsLevel2Memberus-gaap:DesignatedAsHedgingInstrumentMember2020-12-310001751788us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueInputsLevel2Member2020-12-310001751788us-gaap:InterestRateContractMemberus-gaap:NondesignatedMemberdow:DeferredchargesandotherassetsMemberus-gaap:FairValueInputsLevel2Member2020-12-310001751788us-gaap:NondesignatedMemberus-gaap:ForeignExchangeContractMemberus-gaap:OtherCurrentAssetsMemberus-gaap:FairValueInputsLevel2Member2020-12-310001751788us-gaap:NondesignatedMemberus-gaap:CommodityContractMemberus-gaap:OtherCurrentAssetsMemberus-gaap:FairValueInputsLevel2Member2020-12-310001751788us-gaap:NondesignatedMemberus-gaap:FairValueInputsLevel2Member2020-12-310001751788us-gaap:FairValueInputsLevel2Member2020-12-310001751788us-gaap:InterestRateContractMemberus-gaap:FairValueInputsLevel2Memberus-gaap:DesignatedAsHedgingInstrumentMemberdow:AccruedAndOtherCurrentLiabilitiesMember2020-12-310001751788us-gaap:ForeignExchangeContractMemberus-gaap:FairValueInputsLevel2Memberus-gaap:DesignatedAsHedgingInstrumentMemberdow:AccruedAndOtherCurrentLiabilitiesMember2020-12-310001751788us-gaap:CommodityContractMemberus-gaap:FairValueInputsLevel2Memberus-gaap:DesignatedAsHedgingInstrumentMemberdow:AccruedAndOtherCurrentLiabilitiesMember2020-12-310001751788us-gaap:CommodityContractMemberdow:OtherNoncurrentObligationsMemberus-gaap:FairValueInputsLevel2Memberus-gaap:DesignatedAsHedgingInstrumentMember2020-12-310001751788us-gaap:InterestRateSwapMemberus-gaap:NondesignatedMemberdow:OtherNoncurrentObligationsMemberus-gaap:FairValueInputsLevel2Member2020-12-310001751788us-gaap:NondesignatedMemberus-gaap:ForeignExchangeContractMemberus-gaap:FairValueInputsLevel2Memberdow:AccruedAndOtherCurrentLiabilitiesMember2020-12-310001751788us-gaap:NondesignatedMemberus-gaap:CommodityContractMemberus-gaap:FairValueInputsLevel2Memberdow:AccruedAndOtherCurrentLiabilitiesMember2020-12-310001751788dow:ExcludedComponentsMemberus-gaap:DesignatedAsHedgingInstrumentMemberdow:CumulativeTranslationAdjustmentsMemberus-gaap:FairValueHedgingMember2021-04-012021-06-300001751788dow:ExcludedComponentsMemberus-gaap:DesignatedAsHedgingInstrumentMemberdow:CumulativeTranslationAdjustmentsMemberus-gaap:FairValueHedgingMember2020-04-012020-06-300001751788dow:ExcludedComponentsMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueHedgingMember2021-04-012021-06-300001751788dow:ExcludedComponentsMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueHedgingMember2020-04-012020-06-300001751788us-gaap:InterestRateContractMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMember2021-04-012021-06-300001751788us-gaap:InterestRateContractMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMember2020-04-012020-06-300001751788us-gaap:InterestRateContractMemberdow:InterestExpenseAndAmortizationOfDebtDiscountMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMember2021-04-012021-06-300001751788us-gaap:InterestRateContractMemberdow:InterestExpenseAndAmortizationOfDebtDiscountMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMember2020-04-012020-06-300001751788us-gaap:ForeignExchangeContractMemberus-gaap:CostOfSalesMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMember2021-04-012021-06-300001751788us-gaap:ForeignExchangeContractMemberus-gaap:CostOfSalesMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMember2020-04-012020-06-300001751788us-gaap:CommodityContractMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMember2021-04-012021-06-300001751788us-gaap:CommodityContractMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMember2020-04-012020-06-300001751788us-gaap:CommodityContractMemberus-gaap:CostOfSalesMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMember2021-04-012021-06-300001751788us-gaap:CommodityContractMemberus-gaap:CostOfSalesMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMember2020-04-012020-06-300001751788us-gaap:NetInvestmentHedgingMemberus-gaap:ForeignExchangeContractMemberus-gaap:DesignatedAsHedgingInstrumentMember2021-04-012021-06-300001751788us-gaap:NetInvestmentHedgingMemberus-gaap:ForeignExchangeContractMemberus-gaap:DesignatedAsHedgingInstrumentMember2020-04-012020-06-300001751788us-gaap:NetInvestmentHedgingMemberdow:ExcludedComponentsMemberus-gaap:DesignatedAsHedgingInstrumentMemberdow:CumulativeTranslationAdjustmentsMember2021-04-012021-06-300001751788us-gaap:NetInvestmentHedgingMemberdow:ExcludedComponentsMemberus-gaap:DesignatedAsHedgingInstrumentMemberdow:CumulativeTranslationAdjustmentsMember2020-04-012020-06-300001751788us-gaap:NetInvestmentHedgingMemberdow:ExcludedComponentsMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherNonoperatingIncomeExpenseMember2021-04-012021-06-300001751788us-gaap:NetInvestmentHedgingMemberdow:ExcludedComponentsMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherNonoperatingIncomeExpenseMember2020-04-012020-06-300001751788us-gaap:DesignatedAsHedgingInstrumentMember2021-04-012021-06-300001751788us-gaap:DesignatedAsHedgingInstrumentMember2020-04-012020-06-300001751788us-gaap:InterestRateContractMemberus-gaap:NondesignatedMember2021-04-012021-06-300001751788us-gaap:InterestRateContractMemberus-gaap:NondesignatedMember2020-04-012020-06-300001751788us-gaap:InterestRateContractMemberus-gaap:NondesignatedMemberdow:InterestExpenseAndAmortizationOfDebtDiscountMember2021-04-012021-06-300001751788us-gaap:InterestRateContractMemberus-gaap:NondesignatedMemberdow:InterestExpenseAndAmortizationOfDebtDiscountMember2020-04-012020-06-300001751788us-gaap:NondesignatedMemberus-gaap:ForeignExchangeContractMember2021-04-012021-06-300001751788us-gaap:NondesignatedMemberus-gaap:ForeignExchangeContractMember2020-04-012020-06-300001751788us-gaap:NondesignatedMemberus-gaap:ForeignExchangeContractMemberus-gaap:OtherNonoperatingIncomeExpenseMember2021-04-012021-06-300001751788us-gaap:NondesignatedMemberus-gaap:ForeignExchangeContractMemberus-gaap:OtherNonoperatingIncomeExpenseMember2020-04-012020-06-300001751788us-gaap:NondesignatedMemberus-gaap:CommodityContractMember2021-04-012021-06-300001751788us-gaap:NondesignatedMemberus-gaap:CommodityContractMember2020-04-012020-06-300001751788us-gaap:NondesignatedMemberus-gaap:CommodityContractMemberus-gaap:CostOfSalesMember2021-04-012021-06-300001751788us-gaap:NondesignatedMemberus-gaap:CommodityContractMemberus-gaap:CostOfSalesMember2020-04-012020-06-300001751788us-gaap:NondesignatedMember2021-04-012021-06-300001751788us-gaap:NondesignatedMember2020-04-012020-06-300001751788us-gaap:InterestRateContractMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueHedgingMember2021-01-012021-06-300001751788us-gaap:InterestRateContractMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueHedgingMember2020-01-012020-06-300001751788us-gaap:InterestRateContractMemberdow:InterestExpenseAndAmortizationOfDebtDiscountMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueHedgingMember2021-01-012021-06-300001751788us-gaap:InterestRateContractMemberdow:InterestExpenseAndAmortizationOfDebtDiscountMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueHedgingMember2020-01-012020-06-300001751788dow:ExcludedComponentsMemberus-gaap:DesignatedAsHedgingInstrumentMemberdow:CumulativeTranslationAdjustmentsMemberus-gaap:FairValueHedgingMember2021-01-012021-06-300001751788dow:ExcludedComponentsMemberus-gaap:DesignatedAsHedgingInstrumentMemberdow:CumulativeTranslationAdjustmentsMemberus-gaap:FairValueHedgingMember2020-01-012020-06-300001751788dow:ExcludedComponentsMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueHedgingMember2021-01-012021-06-300001751788dow:ExcludedComponentsMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueHedgingMember2020-01-012020-06-300001751788us-gaap:InterestRateContractMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMember2021-01-012021-06-300001751788us-gaap:InterestRateContractMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMember2020-01-012020-06-300001751788us-gaap:InterestRateContractMemberdow:InterestExpenseAndAmortizationOfDebtDiscountMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMember2021-01-012021-06-300001751788us-gaap:InterestRateContractMemberdow:InterestExpenseAndAmortizationOfDebtDiscountMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMember2020-01-012020-06-300001751788us-gaap:ForeignExchangeContractMemberus-gaap:CostOfSalesMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMember2021-01-012021-06-300001751788us-gaap:ForeignExchangeContractMemberus-gaap:CostOfSalesMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMember2020-01-012020-06-300001751788us-gaap:CommodityContractMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMember2021-01-012021-06-300001751788us-gaap:CommodityContractMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMember2020-01-012020-06-300001751788us-gaap:CommodityContractMemberus-gaap:CostOfSalesMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMember2021-01-012021-06-300001751788us-gaap:CommodityContractMemberus-gaap:CostOfSalesMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMember2020-01-012020-06-300001751788us-gaap:NetInvestmentHedgingMemberus-gaap:ForeignExchangeContractMemberus-gaap:DesignatedAsHedgingInstrumentMember2021-01-012021-06-300001751788us-gaap:NetInvestmentHedgingMemberus-gaap:ForeignExchangeContractMemberus-gaap:DesignatedAsHedgingInstrumentMember2020-01-012020-06-300001751788us-gaap:NetInvestmentHedgingMemberdow:ExcludedComponentsMemberus-gaap:DesignatedAsHedgingInstrumentMemberdow:CumulativeTranslationAdjustmentsMember2021-01-012021-06-300001751788us-gaap:NetInvestmentHedgingMemberdow:ExcludedComponentsMemberus-gaap:DesignatedAsHedgingInstrumentMemberdow:CumulativeTranslationAdjustmentsMember2020-01-012020-06-300001751788us-gaap:NetInvestmentHedgingMemberdow:ExcludedComponentsMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherNonoperatingIncomeExpenseMember2021-01-012021-06-300001751788us-gaap:NetInvestmentHedgingMemberdow:ExcludedComponentsMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherNonoperatingIncomeExpenseMember2020-01-012020-06-300001751788us-gaap:DesignatedAsHedgingInstrumentMember2021-01-012021-06-300001751788us-gaap:DesignatedAsHedgingInstrumentMember2020-01-012020-06-300001751788us-gaap:InterestRateContractMemberus-gaap:NondesignatedMember2021-01-012021-06-300001751788us-gaap:InterestRateContractMemberus-gaap:NondesignatedMember2020-01-012020-06-300001751788us-gaap:InterestRateContractMemberus-gaap:NondesignatedMemberdow:InterestExpenseAndAmortizationOfDebtDiscountMember2021-01-012021-06-300001751788us-gaap:InterestRateContractMemberus-gaap:NondesignatedMemberdow:InterestExpenseAndAmortizationOfDebtDiscountMember2020-01-012020-06-300001751788us-gaap:NondesignatedMemberus-gaap:ForeignExchangeContractMember2021-01-012021-06-300001751788us-gaap:NondesignatedMemberus-gaap:ForeignExchangeContractMember2020-01-012020-06-300001751788us-gaap:NondesignatedMemberus-gaap:ForeignExchangeContractMemberus-gaap:OtherNonoperatingIncomeExpenseMember2021-01-012021-06-300001751788us-gaap:NondesignatedMemberus-gaap:ForeignExchangeContractMemberus-gaap:OtherNonoperatingIncomeExpenseMember2020-01-012020-06-300001751788us-gaap:NondesignatedMemberus-gaap:CommodityContractMember2021-01-012021-06-300001751788us-gaap:NondesignatedMemberus-gaap:CommodityContractMember2020-01-012020-06-300001751788us-gaap:NondesignatedMemberus-gaap:CommodityContractMemberus-gaap:CostOfSalesMember2021-01-012021-06-300001751788us-gaap:NondesignatedMemberus-gaap:CommodityContractMemberus-gaap:CostOfSalesMember2020-01-012020-06-300001751788us-gaap:NondesignatedMember2021-01-012021-06-300001751788us-gaap:NondesignatedMember2020-01-012020-06-300001751788dow:ExcludedComponentsMember2021-06-300001751788us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:HeldtomaturitySecuritiesMember2021-06-300001751788us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Memberus-gaap:HeldtomaturitySecuritiesMember2021-06-300001751788us-gaap:FairValueMeasurementsRecurringMemberus-gaap:HeldtomaturitySecuritiesMemberus-gaap:FairValueInputsLevel3Member2021-06-300001751788us-gaap:FairValueMeasurementsRecurringMemberus-gaap:HeldtomaturitySecuritiesMember2021-06-300001751788us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:HeldtomaturitySecuritiesMember2020-12-310001751788us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Memberus-gaap:HeldtomaturitySecuritiesMember2020-12-310001751788us-gaap:FairValueMeasurementsRecurringMemberus-gaap:HeldtomaturitySecuritiesMember2020-12-310001751788us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:MoneyMarketFundsMember2021-06-300001751788us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Memberus-gaap:MoneyMarketFundsMember2021-06-300001751788us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MoneyMarketFundsMember2021-06-300001751788us-gaap:FairValueMeasurementsRecurringMemberus-gaap:MoneyMarketFundsMember2021-06-300001751788us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:MoneyMarketFundsMember2020-12-310001751788us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Memberus-gaap:MoneyMarketFundsMember2020-12-310001751788us-gaap:FairValueMeasurementsRecurringMemberus-gaap:MoneyMarketFundsMember2020-12-310001751788us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2021-06-300001751788us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2021-06-300001751788us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2021-06-300001751788us-gaap:FairValueMeasurementsRecurringMember2021-06-300001751788us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2020-12-310001751788us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2020-12-310001751788us-gaap:FairValueMeasurementsRecurringMember2020-12-310001751788us-gaap:USTreasuryAndGovernmentMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2021-06-300001751788us-gaap:USTreasuryAndGovernmentMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2021-06-300001751788us-gaap:USTreasuryAndGovernmentMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2021-06-300001751788us-gaap:USTreasuryAndGovernmentMemberus-gaap:FairValueMeasurementsRecurringMember2021-06-300001751788us-gaap:USTreasuryAndGovernmentMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2020-12-310001751788us-gaap:USTreasuryAndGovernmentMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2020-12-310001751788us-gaap:USTreasuryAndGovernmentMemberus-gaap:FairValueMeasurementsRecurringMember2020-12-310001751788us-gaap:CorporateDebtSecuritiesMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2021-06-300001751788us-gaap:CorporateDebtSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2021-06-300001751788us-gaap:CorporateDebtSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2021-06-300001751788us-gaap:CorporateDebtSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2021-06-300001751788us-gaap:CorporateDebtSecuritiesMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2020-12-310001751788us-gaap:CorporateDebtSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2020-12-310001751788us-gaap:CorporateDebtSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2020-12-310001751788us-gaap:InterestRateContractMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2021-06-300001751788us-gaap:InterestRateContractMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2021-06-300001751788us-gaap:InterestRateContractMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2021-06-300001751788us-gaap:InterestRateContractMemberus-gaap:FairValueMeasurementsRecurringMember2021-06-300001751788us-gaap:InterestRateContractMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2020-12-310001751788us-gaap:InterestRateContractMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2020-12-310001751788us-gaap:InterestRateContractMemberus-gaap:FairValueMeasurementsRecurringMember2020-12-310001751788us-gaap:ForeignExchangeContractMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2021-06-300001751788us-gaap:ForeignExchangeContractMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2021-06-300001751788us-gaap:ForeignExchangeContractMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2021-06-300001751788us-gaap:ForeignExchangeContractMemberus-gaap:FairValueMeasurementsRecurringMember2021-06-300001751788us-gaap:ForeignExchangeContractMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2020-12-310001751788us-gaap:ForeignExchangeContractMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2020-12-310001751788us-gaap:ForeignExchangeContractMemberus-gaap:FairValueMeasurementsRecurringMember2020-12-310001751788us-gaap:CommodityContractMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2021-06-300001751788us-gaap:CommodityContractMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2021-06-300001751788us-gaap:CommodityContractMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2021-06-300001751788us-gaap:CommodityContractMemberus-gaap:FairValueMeasurementsRecurringMember2021-06-300001751788us-gaap:CommodityContractMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2020-12-310001751788us-gaap:CommodityContractMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2020-12-310001751788us-gaap:CommodityContractMemberus-gaap:FairValueMeasurementsRecurringMember2020-12-310001751788us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberdow:SadaraChemicalCompanyMember2021-06-300001751788us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Memberdow:SadaraChemicalCompanyMember2021-06-300001751788us-gaap:FairValueMeasurementsRecurringMemberdow:SadaraChemicalCompanyMemberus-gaap:FairValueInputsLevel3Member2021-06-300001751788us-gaap:FairValueMeasurementsRecurringMemberdow:SadaraChemicalCompanyMember2021-06-300001751788us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberdow:SadaraChemicalCompanyMember2020-12-310001751788us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Memberdow:SadaraChemicalCompanyMember2020-12-310001751788us-gaap:FairValueMeasurementsRecurringMemberdow:SadaraChemicalCompanyMember2020-12-310001751788us-gaap:FairValueMeasuredAtNetAssetValuePerShareMemberus-gaap:FairValueMeasurementsRecurringMemberdow:PrivateMarketSecuritiesMember2021-06-300001751788us-gaap:FairValueMeasuredAtNetAssetValuePerShareMemberus-gaap:RealEstateMemberus-gaap:FairValueMeasurementsRecurringMember2021-06-300001751788us-gaap:FairValueMeasuredAtNetAssetValuePerShareMemberus-gaap:FairValueMeasurementsRecurringMemberdow:PrivateMarketSecuritiesMember2020-12-310001751788us-gaap:FairValueMeasuredAtNetAssetValuePerShareMemberus-gaap:RealEstateMemberus-gaap:FairValueMeasurementsRecurringMember2020-12-310001751788us-gaap:FairValueMeasuredAtNetAssetValuePerShareMemberus-gaap:FairValueMeasurementsRecurringMemberdow:PrivateMarketSecuritiesandRealEstateMember2021-06-300001751788us-gaap:FairValueMeasuredAtNetAssetValuePerShareMemberus-gaap:FairValueMeasurementsRecurringMemberdow:PrivateMarketSecuritiesandRealEstateMember2020-12-310001751788us-gaap:VariableInterestEntityPrimaryBeneficiaryMember2021-01-012021-06-300001751788us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember2021-01-012021-06-300001751788us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMemberdow:SiliconInputsJointVenturesMember2021-06-300001751788us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMemberdow:SiliconInputsJointVenturesMember2020-12-310001751788dow:TheDowChemicalCompanyMemberdow:DowInc.Member2021-04-012021-06-300001751788dow:TheDowChemicalCompanyMemberdow:DowInc.Member2020-04-012020-06-300001751788dow:TheDowChemicalCompanyMemberdow:DowInc.Member2021-01-012021-06-300001751788dow:TheDowChemicalCompanyMemberdow:DowInc.Member2020-01-012020-06-30
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
☑
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended
June 30, 2021
or
☐
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
For the transition period from
__________to__________
|
|
|
|
|
|
|
|
|
|
|
|
Commission
File Number
|
Exact Name of Registrant as Specified in its Charter,
Principal Office Address and Telephone Number
|
State of Incorporation or
Organization
|
I.R.S. Employer
Identification No.
|
001-38646 |
Dow Inc. |
Delaware |
30-1128146 |
|
2211 H.H. Dow Way, Midland, MI 48674
|
|
|
|
(989) 636-1000
|
|
|
001-03433 |
The Dow Chemical Company |
Delaware |
38-1285128 |
|
2211 H.H. Dow Way, Midland, MI 48674
|
|
|
|
(989) 636-1000
|
|
|
Securities registered pursuant to Section 12(b) of the
Act:
|
|
|
|
|
|
|
|
|
|
|
|
Registrant |
Title of each class |
Trading Symbol(s) |
Name of each exchange on which registered |
Dow Inc. |
Common Stock, par value $0.01 per share |
DOW |
New York Stock Exchange |
The Dow Chemical Company |
0.500% Notes due March 15, 2027 |
DOW/27 |
New York Stock Exchange |
The Dow Chemical Company |
1.125% Notes due March 15, 2032 |
DOW/32 |
New York Stock Exchange |
The Dow Chemical Company |
1.875% Notes due March 15, 2040 |
DOW/40 |
New York Stock Exchange |
The Dow Chemical Company |
4.625% Notes due October 1, 2044 |
DOW/44 |
New York Stock Exchange |
Indicate by check mark whether the registrant (1) has filed
all reports required to be filed by Section 13 or 15(d) of the
Securities Exchange Act of 1934 during the preceding 12 months (or
for such shorter period that the registrant was required to file
such reports), and (2) has been subject to such filing
requirements for the past 90 days.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dow Inc. |
☑ |
Yes |
☐ |
No |
|
The Dow Chemical Company |
☑ |
Yes |
☐ |
No |
Indicate by check mark whether the registrant has submitted
electronically every Interactive Data File required to be submitted
pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter)
during the preceding 12 months (or for such shorter period that the
registrant was required to submit such files).
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dow Inc. |
☑ |
Yes |
☐ |
No |
|
The Dow Chemical Company |
☑ |
Yes |
☐ |
No |
Indicate by check mark whether the registrant is a large
accelerated filer, an accelerated filer, a non-accelerated filer, a
smaller reporting company, or an emerging growth company. See the
definitions of “large accelerated filer,” “accelerated filer,”
“smaller reporting company,” and "emerging growth company" in Rule
12b-2 of the Exchange Act.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dow Inc. |
Large accelerated filer
|
☑ |
Accelerated
filer |
☐ |
Non-accelerated filer |
☐ |
Smaller reporting company |
☐ |
Emerging growth company |
☐ |
The Dow Chemical Company |
Large accelerated filer |
☐ |
Accelerated
filer |
☐ |
Non-accelerated filer
|
☑ |
Smaller reporting company |
☐ |
Emerging growth company |
☐ |
If an emerging growth company, indicate by check mark if the
registrant has elected not to use the extended transition period
for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange
Act.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dow Inc.
|
☐ |
|
The Dow Chemical Company |
☐ |
|
Indicate by check mark whether the registrant is a shell company
(as defined in Rule 12b-2 of the Exchange Act).
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dow Inc. |
☐ |
Yes |
☑ |
No |
|
The Dow Chemical Company |
☐ |
Yes |
☑ |
No |
Dow Inc. had 745,771,788 shares of common stock, $0.01 par value,
outstanding at June 30, 2021. The Dow Chemical Company had
100 shares of common stock, $0.01 par value, outstanding at
June 30, 2021, all of which were held by the registrant’s
parent, Dow Inc.
The Dow Chemical Company meets the conditions set forth in General
Instruction H(1)(a) and (b) for Form 10-Q and therefore is filing
this form with a reduced disclosure format.
Dow Inc. and Subsidiaries
The Dow Chemical Company and Subsidiaries
QUARTERLY REPORT ON FORM 10-Q
For the quarterly period ended June 30, 2021
TABLE OF CONTENTS
|
|
|
|
|
|
|
|
|
|
|
PAGE |
|
|
|
|
|
|
|
|
Item 1. |
|
|
|
Dow Inc. and Subsidiaries: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The Dow Chemical Company and Subsidiaries: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dow Inc. and Subsidiaries and The Dow Chemical Company and
Subsidiaries: |
|
|
|
|
|
|
|
Item 2. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Item 3. |
|
|
|
|
|
Item 4. |
|
|
|
|
|
|
|
|
|
Item 1. |
|
|
|
|
|
Item 1A. |
|
|
|
|
|
Item 2. |
|
|
|
|
|
Item 4. |
|
|
|
|
|
Item 5. |
|
|
|
|
|
Item 6. |
|
|
|
|
|
|
|
|
|
Dow Inc. and Subsidiaries
The Dow Chemical Company and Subsidiaries |
This Quarterly Report on Form 10-Q is a combined report being filed
by Dow Inc. and The Dow Chemical Company and its consolidated
subsidiaries (“TDCC” and together with Dow Inc., “Dow” or the
"Company") due to the parent/subsidiary relationship between Dow
Inc. and TDCC. The information reflected in the report is equally
applicable to both Dow Inc. and TDCC, except where otherwise noted.
Each of Dow Inc. and TDCC is filing information in this report on
its own behalf and neither company makes any representation to the
information relating to the other company.
CAUTIONARY STATEMENT ABOUT FORWARD-LOOKING STATEMENTS
Certain statements in this report are “forward-looking statements”
within the meaning of the federal securities laws, including
Section 27A of the Securities Act of 1933, as amended, and Section
21E of the Securities Exchange Act of 1934, as amended. Such
statements often address expected future business and financial
performance, financial condition, and other matters, and often
contain words or phrases such as “anticipate,” “believe,”
“estimate,” “expect,” “intend,” “may,” “opportunity,” “outlook,”
“plan,” “project,” “seek,” “should,” “strategy,” “target,” “will,”
“will be,” “will continue,” “will likely result,” “would” and
similar expressions, and variations or negatives of these words or
phrases.
Forward-looking statements are based on current assumptions and
expectations of future events that are subject to risks,
uncertainties and other factors that are beyond Dow’s control,
which may cause actual results to differ materially from those
projected, anticipated or implied in the forward-looking statements
and speak only as of the date the statements were made. These
factors include, but are not limited to: sales of Dow’s products;
Dow’s expenses, future revenues and profitability; the continuing
global and regional economic impacts of the coronavirus disease
2019 (“COVID-19”) pandemic and other public health-related risks
and events on Dow’s business; capital requirements and need for and
availability of financing; size of the markets for Dow’s products
and services and ability to compete in such markets; failure to
develop and market new products and optimally manage product life
cycles; the rate and degree of market acceptance of Dow’s products;
significant litigation and environmental matters and related
contingencies and unexpected expenses; the success of competing
technologies that are or may become available; the ability to
protect Dow’s intellectual property in the United States and
abroad; developments related to contemplated restructuring
activities and proposed divestitures or acquisitions such as
workforce reduction, manufacturing facility and/or asset closure
and related exit and disposal activities, and the benefits and
costs associated with each of the foregoing; fluctuations in energy
and raw material prices; management of process safety and product
stewardship; changes in relationships with Dow’s significant
customers and suppliers; changes in consumer preferences and
demand; changes in laws and regulations, political conditions or
industry development; global economic and capital markets
conditions, such as inflation, market uncertainty, interest and
currency exchange rates, and equity and commodity prices; business
or supply disruptions; security threats, such as acts of sabotage,
terrorism or war; weather events and natural disasters; and
disruptions in Dow’s information technology networks and
systems.
Risks related to Dow’s separation from DowDuPont Inc. include, but
are not limited to: (i) Dow’s inability to achieve some or all of
the benefits that it expects to receive from the separation from
DowDuPont Inc.; (ii) certain tax risks associated with the
separation; (iii) the failure of Dow’s pro forma financial
information to be a reliable indicator of Dow’s future results;
(iv) non-compete restrictions under the separation agreement; (v)
receipt of less favorable terms in the commercial agreements Dow
entered into with DuPont de Nemours, Inc. ("DuPont") and Corteva,
Inc. (“Corteva”), including restrictions under intellectual
property cross-license agreements, than Dow would have received
from an unaffiliated third party; and (vi) Dow’s obligation to
indemnify DuPont and/or Corteva for certain
liabilities.
Where, in any forward-looking statement, an expectation or belief
as to future results or events is expressed, such expectation or
belief is based on the current plans and expectations of management
and expressed in good faith and believed to have a reasonable
basis, but there can be no assurance that the expectation or belief
will result or be achieved or accomplished. A detailed discussion
of principal risks and uncertainties which may cause actual results
and events to differ materially from such forward-looking
statements is included in the section titled “Risk Factors”
contained in the Company’s Annual Report on Form 10-K for the year
ended December 31, 2020. These are not the only risks and
uncertainties that Dow faces. There may be other risks and
uncertainties that Dow is unable to identify at this time or that
Dow does not currently expect to have a material impact on its
business. If any of those risks or uncertainties develops into an
actual event, it could have a material adverse effect on Dow’s
business. Dow assumes no obligation to update or revise publicly
any forward-looking statements whether because of new information,
future events, or otherwise, except as required by securities and
other applicable laws.
|
|
|
PART I – FINANCIAL INFORMATION |
|
|
|
ITEM 1. FINANCIAL STATEMENTS |
Dow Inc. and Subsidiaries
Consolidated Statements of Income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
Six Months Ended |
In millions, except per share amounts (Unaudited) |
Jun 30,
2021 |
Jun 30,
2020 |
Jun 30,
2021 |
Jun 30,
2020 |
Net sales |
$ |
13,885 |
|
$ |
8,354 |
|
$ |
25,767 |
|
$ |
18,124 |
|
Cost of sales |
10,740 |
|
7,610 |
|
20,802 |
|
15,840 |
|
Research and development expenses |
228 |
|
182 |
|
422 |
|
361 |
|
Selling, general and administrative expenses |
440 |
|
357 |
|
806 |
|
691 |
|
Amortization of intangibles |
100 |
|
100 |
|
201 |
|
200 |
|
Restructuring and asset related charges - net |
22 |
|
6 |
|
22 |
|
102 |
|
Integration and separation costs |
— |
|
46 |
|
— |
|
111 |
|
Equity in earnings (losses) of nonconsolidated
affiliates |
278 |
|
(95) |
|
502 |
|
(184) |
|
Sundry income (expense) - net |
(3) |
|
53 |
|
125 |
|
(28) |
|
Interest income |
13 |
|
6 |
|
21 |
|
21 |
|
Interest expense and amortization of debt discount |
187 |
|
200 |
|
383 |
|
415 |
|
Income (loss) before income taxes |
2,456 |
|
(183) |
|
3,779 |
|
213 |
|
Provision for income taxes |
524 |
|
34 |
|
841 |
|
172 |
|
Net income (loss) |
1,932 |
|
(217) |
|
2,938 |
|
41 |
|
Net income attributable to noncontrolling interests |
31 |
|
8 |
|
46 |
|
27 |
|
Net income (loss) available for Dow Inc. common
stockholders |
$ |
1,901 |
|
$ |
(225) |
|
$ |
2,892 |
|
$ |
14 |
|
|
|
|
|
|
Per common share data: |
|
|
|
|
Earnings (loss) per common share - basic |
$ |
2.53 |
|
$ |
(0.31) |
|
$ |
3.86 |
|
$ |
0.01 |
|
Earnings (loss) per common share - diluted |
$ |
2.51 |
|
$ |
(0.31) |
|
$ |
3.83 |
|
$ |
0.01 |
|
|
|
|
|
|
Weighted-average common shares outstanding - basic |
747.0 |
|
739.3 |
|
745.9 |
|
739.7 |
|
Weighted-average common shares outstanding - diluted |
752.9 |
|
739.3 |
|
751.4 |
|
741.0 |
|
|
|
|
|
|
Depreciation |
$ |
518 |
|
$ |
517 |
|
$ |
1,033 |
|
$ |
1,032 |
|
Capital expenditures |
$ |
333 |
|
$ |
273 |
|
$ |
622 |
|
$ |
668 |
|
See Notes to the Consolidated Financial Statements.
Dow Inc. and Subsidiaries
Consolidated Statements of Comprehensive Income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
Six Months Ended |
In millions (Unaudited) |
Jun 30,
2021 |
Jun 30,
2020 |
Jun 30,
2021 |
Jun 30,
2020 |
Net income (loss) |
$ |
1,932 |
|
$ |
(217) |
|
$ |
2,938 |
|
$ |
41 |
|
Other comprehensive income (loss), net of tax |
|
|
|
|
Unrealized gains (losses) on investments |
17 |
|
76 |
|
(32) |
|
(24) |
|
Cumulative translation adjustments |
65 |
|
63 |
|
(188) |
|
(100) |
|
Pension and other postretirement benefit plans |
149 |
|
141 |
|
1,283 |
|
283 |
|
Derivative instruments |
6 |
|
24 |
|
116 |
|
(138) |
|
Total other comprehensive income |
237 |
|
304 |
|
1,179 |
|
21 |
|
Comprehensive income |
2,169 |
|
87 |
|
4,117 |
|
62 |
|
Comprehensive income attributable to noncontrolling interests, net
of tax |
31 |
|
8 |
|
46 |
|
27 |
|
Comprehensive income attributable to Dow Inc. |
$ |
2,138 |
|
$ |
79 |
|
$ |
4,071 |
|
$ |
35 |
|
See Notes to the Consolidated Financial Statements.
Dow Inc. and Subsidiaries
Consolidated Balance Sheets
|
|
|
|
|
|
|
|
|
In millions, except share amounts (Unaudited)
|
Jun 30,
2021 |
Dec 31,
2020 |
Assets |
|
|
Current Assets |
|
|
Cash and cash equivalents (variable interest entities restricted -
2021: $36; 2020: $26)
|
$ |
3,491 |
|
$ |
5,104 |
|
|
|
|
Accounts and notes receivable: |
|
|
Trade (net of allowance for doubtful receivables - 2021: $59; 2020:
$51)
|
6,456 |
|
4,839 |
|
Other |
2,650 |
|
2,551 |
|
Inventories |
6,952 |
|
5,701 |
|
Other current assets |
803 |
|
889 |
|
Total current assets |
20,352 |
|
19,084 |
|
Investments |
|
|
Investment in nonconsolidated affiliates |
1,754 |
|
1,327 |
|
Other investments (investments carried at fair value - 2021:
$1,655; 2020: $1,674)
|
2,764 |
|
2,775 |
|
Noncurrent receivables |
480 |
|
465 |
|
Total investments |
4,998 |
|
4,567 |
|
Property |
|
|
Property |
56,564 |
|
56,325 |
|
Less: Accumulated depreciation |
36,700 |
|
36,086 |
|
Net property (variable interest entities restricted - 2021: $204;
2020: $232)
|
19,864 |
|
20,239 |
|
Other Assets |
|
|
Goodwill |
8,833 |
|
8,908 |
|
Other intangible assets (net of accumulated amortization - 2021:
$4,650; 2020: $4,428)
|
3,093 |
|
3,352 |
|
Operating lease right-of-use assets |
1,745 |
|
1,856 |
|
Deferred income tax assets |
1,529 |
|
2,215 |
|
Deferred charges and other assets |
1,354 |
|
1,249 |
|
Total other assets |
16,554 |
|
17,580 |
|
Total Assets |
$ |
61,768 |
|
$ |
61,470 |
|
Liabilities and Equity |
|
|
Current Liabilities |
|
|
Notes payable |
$ |
203 |
|
$ |
156 |
|
Long-term debt due within one year |
445 |
|
460 |
|
Accounts payable: |
|
|
Trade |
4,664 |
|
3,763 |
|
Other |
2,638 |
|
2,126 |
|
Operating lease liabilities - current |
402 |
|
416 |
|
Income taxes payable |
462 |
|
397 |
|
|
|
|
Accrued and other current liabilities |
3,494 |
|
3,790 |
|
Total current liabilities |
12,308 |
|
11,108 |
|
Long-Term Debt (variable interest entities nonrecourse - 2021: $5;
2020: $6)
|
15,093 |
|
16,491 |
|
Other Noncurrent Liabilities |
|
|
Deferred income tax liabilities |
504 |
|
405 |
|
Pension and other postretirement benefits - noncurrent |
8,888 |
|
11,648 |
|
Asbestos-related liabilities - noncurrent |
975 |
|
1,013 |
|
Operating lease liabilities - noncurrent |
1,419 |
|
1,521 |
|
Other noncurrent obligations |
6,428 |
|
6,279 |
|
Total other noncurrent liabilities |
18,214 |
|
20,866 |
|
Stockholders’ Equity |
|
|
Common stock (authorized 5,000,000,000 shares of $0.01 par value
each;
issued 2021: 761,524,466 shares; 2020: 755,993,198
shares)
|
8 |
|
8 |
|
Additional paid-in capital |
7,898 |
|
7,595 |
|
Retained earnings |
18,200 |
|
16,361 |
|
Accumulated other comprehensive loss |
(9,676) |
|
(10,855) |
|
Unearned ESOP shares |
(32) |
|
(49) |
|
Treasury stock at cost (2021: 15,752,678 shares; 2020: 12,803,303
shares)
|
(825) |
|
(625) |
|
Dow Inc.’s stockholders’ equity |
15,573 |
|
12,435 |
|
Noncontrolling interests |
580 |
|
570 |
|
Total equity |
16,153 |
|
13,005 |
|
Total Liabilities and Equity |
$ |
61,768 |
|
$ |
61,470 |
|
See Notes to the Consolidated Financial Statements.
Dow Inc. and Subsidiaries
Consolidated Statements of Cash Flows
|
|
|
|
|
|
|
|
|
In millions (Unaudited) |
Six Months Ended |
Jun 30,
2021 |
Jun 30,
2020 |
Operating Activities |
|
|
Net income |
$ |
2,938 |
|
$ |
41 |
|
Adjustments to reconcile net income to net cash provided by
operating activities: |
|
|
Depreciation and amortization |
1,462 |
|
1,424 |
|
Provision (credit) for deferred income tax |
388 |
|
(59) |
|
Earnings of nonconsolidated affiliates less than (in excess of)
dividends received |
(283) |
|
455 |
|
Net periodic pension benefit cost |
29 |
|
129 |
|
Pension contributions |
(1,109) |
|
(112) |
|
Net gain on sales of assets, businesses and investments |
(50) |
|
(39) |
|
|
|
|
Restructuring and asset related charges - net |
22 |
|
102 |
|
Other net loss |
224 |
|
163 |
|
Changes in assets and liabilities, net of effects of acquired and
divested companies: |
|
|
Accounts and notes receivable |
(1,903) |
|
696 |
|
Inventories |
(1,278) |
|
429 |
|
Accounts payable |
1,357 |
|
(896) |
|
Other assets and liabilities, net |
(4) |
|
502 |
|
Cash provided by operating activities - continuing
operations |
1,793 |
|
2,835 |
|
Cash used for operating activities - discontinued
operations |
(80) |
|
(6) |
|
Cash provided by operating activities |
1,713 |
|
2,829 |
|
Investing Activities |
|
|
Capital expenditures |
(622) |
|
(668) |
|
Investment in gas field developments |
(24) |
|
(5) |
|
Purchases of previously leased assets |
(3) |
|
(2) |
|
Proceeds from sales of property and businesses, net of cash
divested |
10 |
|
14 |
|
Acquisitions of property and businesses, net of cash
acquired |
(107) |
|
— |
|
Investments in and loans to nonconsolidated affiliates |
— |
|
(236) |
|
Distributions and loan repayments from nonconsolidated
affiliates |
11 |
|
6 |
|
Purchases of investments |
(560) |
|
(462) |
|
Proceeds from sales and maturities of investments |
527 |
|
790 |
|
|
|
|
Other investing activities, net |
— |
|
29 |
|
Cash used for investing activities |
(768) |
|
(534) |
|
Financing Activities |
|
|
Changes in short-term notes payable |
(38) |
|
181 |
|
Proceeds from issuance of short-term debt greater than three
months |
72 |
|
163 |
|
Payments on short-term debt greater than three months |
— |
|
(100) |
|
Proceeds from issuance of long-term debt |
68 |
|
2,509 |
|
Payments on long-term debt |
(1,425) |
|
(2,359) |
|
Purchases of treasury stock |
(200) |
|
(125) |
|
Proceeds from issuance of stock |
200 |
|
30 |
|
Transaction financing, debt issuance and other costs |
(95) |
|
(99) |
|
Employee taxes paid for share-based payment
arrangements |
(11) |
|
(26) |
|
Distributions to noncontrolling interests |
(28) |
|
(19) |
|
|
|
|
Dividends paid to stockholders |
(1,043) |
|
(1,034) |
|
|
|
|
|
|
|
|
|
|
Cash used for financing activities |
(2,500) |
|
(879) |
|
Effect of exchange rate changes on cash, cash equivalents and
restricted cash |
(12) |
|
(66) |
|
|
|
|
Summary |
|
|
Increase (decrease) in cash, cash equivalents and restricted
cash |
(1,567) |
|
1,350 |
|
Cash, cash equivalents and restricted cash at beginning of
period |
5,108 |
|
2,380 |
|
Cash, cash equivalents and restricted cash at end of
period |
$ |
3,541 |
|
$ |
3,730 |
|
Less: Restricted cash and cash equivalents, included in "Other
current assets" |
50 |
|
6 |
|
Cash and cash equivalents at end of period |
$ |
3,491 |
|
$ |
3,724 |
|
See Notes to the Consolidated Financial Statements.
Dow Inc. and Subsidiaries
Consolidated Statements of Equity
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
Six Months Ended |
In millions, except per share amounts (Unaudited) |
Jun 30,
2021 |
Jun 30,
2020 |
Jun 30,
2021 |
Jun 30,
2020 |
Common Stock |
|
|
|
|
Balance at beginning and end of period |
$ |
8 |
|
$ |
8 |
|
$ |
8 |
|
$ |
8 |
|
|
|
|
|
|
|
|
|
|
|
Additional Paid-in Capital |
|
|
|
|
Balance at beginning of period |
7,743 |
|
7,370 |
|
7,595 |
|
7,325 |
|
Common stock issued/sold |
73 |
|
14 |
|
200 |
|
30 |
|
|
|
|
|
|
Stock-based compensation and allocation of ESOP shares |
82 |
|
47 |
|
103 |
|
76 |
|
|
|
|
|
|
Balance at end of period |
7,898 |
|
7,431 |
|
7,898 |
|
7,431 |
|
Retained Earnings |
|
|
|
|
Balance at beginning of period |
16,829 |
|
16,763 |
|
16,361 |
|
17,045 |
|
Net income (loss) available for Dow Inc. common
stockholders |
1,901 |
|
(225) |
|
2,892 |
|
14 |
|
Dividends to stockholders |
(522) |
|
(516) |
|
(1,043) |
|
(1,034) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other |
(8) |
|
(5) |
|
(10) |
|
(8) |
|
Balance at end of period |
18,200 |
|
16,017 |
|
18,200 |
|
16,017 |
|
Accumulated Other Comprehensive Loss |
|
|
|
|
Balance at beginning of period |
(9,913) |
|
(10,529) |
|
(10,855) |
|
(10,246) |
|
Other comprehensive income |
237 |
|
304 |
|
1,179 |
|
21 |
|
|
|
|
|
|
Balance at end of period |
(9,676) |
|
(10,225) |
|
(9,676) |
|
(10,225) |
|
Unearned ESOP Shares |
|
|
|
|
Balance at beginning of period |
(39) |
|
(81) |
|
(49) |
|
(91) |
|
|
|
|
|
|
Allocation of ESOP shares |
7 |
|
12 |
|
17 |
|
22 |
|
Balance at end of period |
(32) |
|
(69) |
|
(32) |
|
(69) |
|
Treasury Stock |
|
|
|
|
Balance at beginning of period |
(625) |
|
(625) |
|
(625) |
|
(500) |
|
Treasury stock purchases |
(200) |
|
— |
|
(200) |
|
(125) |
|
Balance at end of period |
(825) |
|
(625) |
|
(825) |
|
(625) |
|
Dow Inc.'s stockholders' equity |
15,573 |
|
12,537 |
|
15,573 |
|
12,537 |
|
Noncontrolling Interests |
580 |
|
560 |
|
580 |
|
560 |
|
Total Equity |
$ |
16,153 |
|
$ |
13,097 |
|
$ |
16,153 |
|
$ |
13,097 |
|
|
|
|
|
|
Dividends declared per share of common stock |
$ |
0.70 |
|
$ |
0.70 |
|
$ |
1.40 |
|
$ |
1.40 |
|
See Notes to the Consolidated Financial Statements.
The Dow Chemical Company and Subsidiaries
Consolidated Statements of Income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
Six Months Ended |
In millions (Unaudited) |
Jun 30,
2021 |
Jun 30,
2020 |
Jun 30,
2021 |
Jun 30,
2020 |
Net sales |
$ |
13,885 |
|
$ |
8,354 |
|
$ |
25,767 |
|
$ |
18,124 |
|
Cost of sales |
10,739 |
|
7,608 |
|
20,800 |
|
15,838 |
|
Research and development expenses |
228 |
|
182 |
|
422 |
|
361 |
|
Selling, general and administrative expenses |
440 |
|
356 |
|
806 |
|
690 |
|
Amortization of intangibles |
100 |
|
100 |
|
201 |
|
200 |
|
Restructuring and asset related charges - net |
22 |
|
6 |
|
22 |
|
102 |
|
Integration and separation costs |
— |
|
46 |
|
— |
|
111 |
|
Equity in earnings (losses) of nonconsolidated
affiliates |
278 |
|
(95) |
|
502 |
|
(184) |
|
Sundry income (expense) - net |
6 |
|
51 |
|
125 |
|
(31) |
|
Interest income |
13 |
|
5 |
|
21 |
|
21 |
|
Interest expense and amortization of debt discount |
187 |
|
200 |
|
383 |
|
415 |
|
Income (loss) before income taxes |
2,466 |
|
(183) |
|
3,781 |
|
213 |
|
Provision for income taxes |
521 |
|
34 |
|
838 |
|
172 |
|
Net income (loss) |
1,945 |
|
(217) |
|
2,943 |
|
41 |
|
Net income attributable to noncontrolling interests |
31 |
|
8 |
|
46 |
|
27 |
|
Net income (loss) available for The Dow Chemical Company common
stockholder |
$ |
1,914 |
|
$ |
(225) |
|
$ |
2,897 |
|
$ |
14 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Depreciation |
$ |
518 |
|
$ |
517 |
|
$ |
1,033 |
|
$ |
1,032 |
|
Capital expenditures |
$ |
333 |
|
$ |
273 |
|
$ |
622 |
|
$ |
668 |
|
See Notes to the Consolidated Financial Statements.
The Dow Chemical Company and Subsidiaries
Consolidated Statements of Comprehensive Income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
Six Months Ended |
In millions (Unaudited) |
Jun 30,
2021 |
Jun 30,
2020 |
Jun 30,
2021 |
Jun 30,
2020 |
Net income (loss) |
$ |
1,945 |
|
$ |
(217) |
|
$ |
2,943 |
|
$ |
41 |
|
Other comprehensive income (loss), net of tax |
|
|
|
|
Unrealized gains (losses) on investments |
17 |
|
76 |
|
(32) |
|
(24) |
|
Cumulative translation adjustments |
65 |
|
63 |
|
(188) |
|
(100) |
|
Pension and other postretirement benefit plans |
149 |
|
141 |
|
1,283 |
|
283 |
|
Derivative instruments |
6 |
|
24 |
|
116 |
|
(138) |
|
Total other comprehensive income |
237 |
|
304 |
|
1,179 |
|
21 |
|
Comprehensive income |
2,182 |
|
87 |
|
4,122 |
|
62 |
|
Comprehensive income attributable to noncontrolling interests, net
of tax |
31 |
|
8 |
|
46 |
|
27 |
|
Comprehensive income attributable to The Dow Chemical
Company |
$ |
2,151 |
|
$ |
79 |
|
$ |
4,076 |
|
$ |
35 |
|
See Notes to the Consolidated Financial Statements.
The Dow Chemical Company and Subsidiaries
Consolidated Balance Sheets
|
|
|
|
|
|
|
|
|
In millions, except share amounts (Unaudited)
|
Jun 30,
2021 |
Dec 31,
2020 |
Assets |
|
|
Current Assets |
|
|
Cash and cash equivalents (variable interest entities restricted -
2021: $36; 2020: $26)
|
$ |
3,491 |
|
$ |
5,104 |
|
|
|
|
Accounts and notes receivable: |
|
|
Trade (net of allowance for doubtful receivables - 2021: $59; 2020:
$51)
|
6,456 |
|
4,839 |
|
Other |
2,653 |
|
2,553 |
|
Inventories |
6,952 |
|
5,701 |
|
Other current assets |
759 |
|
801 |
|
Total current assets |
20,311 |
|
18,998 |
|
Investments |
|
|
Investment in nonconsolidated affiliates |
1,754 |
|
1,327 |
|
Other investments (investments carried at fair value - 2021:
$1,655; 2020: $1,674)
|
2,764 |
|
2,775 |
|
Noncurrent receivables |
442 |
|
426 |
|
Total investments |
4,960 |
|
4,528 |
|
Property |
|
|
Property |
56,564 |
|
56,325 |
|
Less accumulated depreciation |
36,700 |
|
36,086 |
|
Net property (variable interest entities restricted - 2021: $204;
2020: $232)
|
19,864 |
|
20,239 |
|
Other Assets |
|
|
Goodwill |
8,833 |
|
8,908 |
|
Other intangible assets (net of accumulated amortization - 2021:
$4,650; 2020: $4,428)
|
3,093 |
|
3,352 |
|
Operating lease right-of-use assets |
1,745 |
|
1,856 |
|
Deferred income tax assets |
1,529 |
|
2,215 |
|
Deferred charges and other assets |
1,354 |
|
1,249 |
|
Total other assets |
16,554 |
|
17,580 |
|
Total Assets |
$ |
61,689 |
|
$ |
61,345 |
|
Liabilities and Equity |
|
|
Current Liabilities |
|
|
Notes payable |
$ |
203 |
|
$ |
156 |
|
Long-term debt due within one year |
445 |
|
460 |
|
Accounts payable: |
|
|
Trade |
4,664 |
|
3,763 |
|
Other |
2,638 |
|
2,126 |
|
Operating lease liabilities - current |
402 |
|
416 |
|
Income taxes payable |
462 |
|
397 |
|
|
|
|
Accrued and other current liabilities |
3,198 |
|
3,256 |
|
Total current liabilities |
12,012 |
|
10,574 |
|
Long-Term Debt (variable interest entities nonrecourse - 2021: $5;
2020: $6)
|
15,093 |
|
16,491 |
|
Other Noncurrent Liabilities |
|
|
Deferred income tax liabilities |
504 |
|
405 |
|
Pension and other postretirement benefits - noncurrent |
8,888 |
|
11,648 |
|
Asbestos-related liabilities - noncurrent |
975 |
|
1,013 |
|
Operating lease liabilities - noncurrent |
1,419 |
|
1,521 |
|
Other noncurrent obligations |
6,275 |
|
6,124 |
|
Total other noncurrent liabilities |
18,061 |
|
20,711 |
|
Stockholder's Equity |
|
|
Common stock (authorized and issued 100 shares of $0.01 par value
each)
|
— |
|
— |
|
Additional paid-in capital |
7,906 |
|
7,603 |
|
Retained earnings |
17,745 |
|
16,300 |
|
Accumulated other comprehensive loss |
(9,676) |
|
(10,855) |
|
Unearned ESOP shares |
(32) |
|
(49) |
|
|
|
|
The Dow Chemical Company’s stockholder's equity |
15,943 |
|
12,999 |
|
Noncontrolling interests |
580 |
|
570 |
|
Total equity |
16,523 |
|
13,569 |
|
Total Liabilities and Equity |
$ |
61,689 |
|
$ |
61,345 |
|
See Notes to the Consolidated Financial Statements.
The Dow Chemical Company and Subsidiaries
Consolidated Statements of Cash Flows
|
|
|
|
|
|
|
|
|
In millions (Unaudited) |
Six Months Ended |
Jun 30,
2021 |
Jun 30,
2020 |
Operating Activities |
|
|
Net income |
$ |
2,943 |
|
$ |
41 |
|
Adjustments to reconcile net income to net cash provided by
operating activities: |
|
|
Depreciation and amortization |
1,462 |
|
1,424 |
|
Provision (credit) for deferred income tax |
388 |
|
(59) |
|
Earnings of nonconsolidated affiliates less than (in excess of)
dividends received |
(283) |
|
455 |
|
Net periodic pension benefit cost |
29 |
|
129 |
|
Pension contributions |
(1,109) |
|
(112) |
|
Net gain on sales of assets, businesses and investments |
(50) |
|
(39) |
|
|
|
|
Restructuring and asset related charges - net |
22 |
|
102 |
|
Other net loss |
224 |
|
167 |
|
Changes in assets and liabilities, net of effects of acquired and
divested companies: |
|
|
Accounts and notes receivable |
(1,903) |
|
696 |
|
Inventories |
(1,278) |
|
429 |
|
Accounts payable |
1,357 |
|
(896) |
|
Other assets and liabilities, net |
110 |
|
505 |
|
Cash provided by operating activities |
1,912 |
|
2,842 |
|
Investing Activities |
|
|
Capital expenditures |
(622) |
|
(668) |
|
Investment in gas field developments |
(24) |
|
(5) |
|
Purchases of previously leased assets |
(3) |
|
(2) |
|
Proceeds from sales of property and businesses, net of cash
divested |
10 |
|
14 |
|
Acquisitions of property and businesses, net of cash
acquired |
(107) |
|
— |
|
Investments in and loans to nonconsolidated affiliates |
— |
|
(236) |
|
Distributions and loan repayments from nonconsolidated
affiliates |
11 |
|
6 |
|
Purchases of investments |
(560) |
|
(462) |
|
Proceeds from sales and maturities of investments |
527 |
|
790 |
|
|
|
|
Other investing activities, net |
— |
|
29 |
|
Cash used for investing activities |
(768) |
|
(534) |
|
Financing Activities |
|
|
Changes in short-term notes payable |
(38) |
|
181 |
|
Proceeds from issuance of short-term debt greater than three
months |
72 |
|
163 |
|
Payments on short-term debt greater than three months |
— |
|
(100) |
|
|
|
|
Proceeds from issuance of long-term debt |
68 |
|
2,509 |
|
Payments on long-term debt |
(1,425) |
|
(2,359) |
|
|
|
|
Proceeds from issuance of stock |
200 |
|
30 |
|
Transaction financing, debt issuance and other costs |
(95) |
|
(99) |
|
Employee taxes paid for share-based payment
arrangements |
(11) |
|
(26) |
|
Distributions to noncontrolling interests |
(28) |
|
(19) |
|
|
|
|
Dividends paid to Dow Inc. |
(1,442) |
|
(1,172) |
|
|
|
|
|
|
|
|
|
|
Cash used for financing activities |
(2,699) |
|
(892) |
|
Effect of exchange rate changes on cash, cash equivalents and
restricted cash |
(12) |
|
(66) |
|
|
|
|
Summary |
|
|
Increase (decrease) in cash, cash equivalents and restricted
cash |
(1,567) |
|
1,350 |
|
Cash, cash equivalents and restricted cash at beginning of
period |
5,108 |
|
2,380 |
|
Cash, cash equivalents and restricted cash at end of
period |
$ |
3,541 |
|
$ |
3,730 |
|
Less: Restricted cash and cash equivalents, included in "Other
current assets" |
50 |
|
6 |
|
Cash and cash equivalents at end of period |
$ |
3,491 |
|
$ |
3,724 |
|
See Notes to the Consolidated Financial Statements.
The Dow Chemical Company and Subsidiaries
Consolidated Statements of Equity
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
Six Months Ended |
In millions (Unaudited) |
Jun 30,
2021 |
Jun 30,
2020 |
Jun 30,
2021 |
Jun 30,
2020 |
Common Stock |
|
|
|
|
Balance at beginning and end of period |
$ |
— |
|
$ |
— |
|
$ |
— |
|
$ |
— |
|
Additional Paid-in Capital |
|
|
|
|
Balance at beginning of period |
7,751 |
|
7,378 |
|
7,603 |
|
7,333 |
|
Issuance of parent company stock - Dow Inc. |
73 |
|
14 |
|
200 |
|
30 |
|
Stock-based compensation and allocation of ESOP shares |
82 |
|
47 |
|
103 |
|
76 |
|
|
|
|
|
|
Balance at end of period |
7,906 |
|
7,439 |
|
7,906 |
|
7,439 |
|
Retained Earnings |
|
|
|
|
Balance at beginning of period |
16,577 |
|
16,905 |
|
16,300 |
|
17,313 |
|
Net income (loss) available for The Dow Chemical Company
common stockholder |
1,914 |
|
(225) |
|
2,897 |
|
14 |
|
Dividends to Dow Inc. |
(739) |
|
(529) |
|
(1,442) |
|
(1,172) |
|
|
|
|
|
|
|
|
|
|
|
Other |
(7) |
|
(4) |
|
(10) |
|
(8) |
|
Balance at end of period |
17,745 |
|
16,147 |
|
17,745 |
|
16,147 |
|
Accumulated Other Comprehensive Loss |
|
|
|
|
Balance at beginning of period |
(9,913) |
|
(10,529) |
|
(10,855) |
|
(10,246) |
|
Other comprehensive income |
237 |
|
304 |
|
1,179 |
|
21 |
|
|
|
|
|
|
Balance at end of period |
(9,676) |
|
(10,225) |
|
(9,676) |
|
(10,225) |
|
Unearned ESOP Shares |
|
|
|
|
Balance at beginning of period |
(39) |
|
(81) |
|
(49) |
|
(91) |
|
|
|
|
|
|
Allocation of ESOP shares |
7 |
|
12 |
|
17 |
|
22 |
|
Balance at end of period |
(32) |
|
(69) |
|
(32) |
|
(69) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The Dow Chemical Company's stockholder's equity |
15,943 |
|
13,292 |
|
15,943 |
|
13,292 |
|
Noncontrolling Interests |
580 |
|
560 |
|
580 |
|
560 |
|
Total Equity |
$ |
16,523 |
|
$ |
13,852 |
|
$ |
16,523 |
|
$ |
13,852 |
|
See Notes to the Consolidated Financial Statements.
|
|
|
Dow Inc. and Subsidiaries
The Dow Chemical Company and Subsidiaries
(Unaudited)
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
Table of Contents
|
|
|
|
|
|
|
|
|
Note |
|
Page |
1 |
|
|
2 |
|
|
3 |
|
|
4 |
|
|
5 |
|
|
6 |
|
|
7 |
|
|
8 |
|
|
9 |
|
|
10 |
|
|
11 |
|
|
12 |
|
|
13 |
|
|
14 |
|
|
15 |
|
|
16 |
|
|
17 |
|
|
18 |
|
|
19 |
|
|
20 |
|
|
21 |
|
|
22 |
|
|
NOTE 1 – CONSOLIDATED FINANCIAL STATEMENTS
Basis of Presentation
Dow Inc. is the direct parent company of The Dow Chemical Company
and its consolidated subsidiaries ("TDCC" and together with Dow
Inc., "Dow" or the "Company"). The unaudited interim consolidated
financial statements of Dow Inc. and TDCC were prepared in
accordance with accounting principles generally accepted in the
United States of America (“U.S. GAAP”) and reflect all adjustments
(including normal recurring accruals) which, in the opinion of
management, are considered necessary for the fair presentation of
the results for the periods presented. These statements should be
read in conjunction with the audited consolidated financial
statements and notes thereto included in the combined Dow Inc. and
TDCC Annual Report on Form 10-K for the year ended
December 31, 2020 ("2020 10-K").
As a result of the parent/subsidiary relationship between Dow Inc.
and TDCC, and considering that the financial statements and
disclosures of each company are substantially similar, the
companies are filing a combined report for this Quarterly Report on
Form 10-Q. The information reflected in the report is equally
applicable to both Dow Inc. and TDCC, except where otherwise noted.
Transactions between TDCC and Dow Inc. are treated as related party
transactions for TDCC. See Note 21 for additional
information.
Except as otherwise indicated by the context, the term "Union
Carbide" means Union Carbide Corporation and the term "Dow
Silicones" means Dow Silicones Corporation, both wholly owned
subsidiaries of the Company.
NOTE 2 – RECENT ACCOUNTING GUIDANCE
Recently Adopted Accounting Guidance
In the first quarter of 2021, the Company adopted Accounting
Standards Update 2019-12, "Income Taxes (Topic 740):
Simplifying the Accounting for Income Taxes." The amendments
simplify the accounting for income taxes by removing certain
exceptions to the general principles of Topic 740, "Income Taxes"
and improve consistent application by clarifying and amending
existing guidance. The adoption of this guidance did not have a
material impact on the consolidated financial
statements.
NOTE 3 – SEPARATION FROM DOWDUPONT
For additional information on the separation from DowDuPont Inc.
("DowDuPont"), see Note 3 to the Consolidated Financial Statements
included in the 2020 10-K.
Agreements Related to the Separation and Distribution
Dow Inc. entered into certain agreements with DuPont de Nemours,
Inc. ("DuPont") and/or Corteva Inc. ("Corteva"), including the
following: Separation and Distribution Agreement, Tax Matters
Agreement and Employee Matters Agreement (collectively, the
"Agreements"). In addition to establishing the terms of Dow Inc.'s
separation from DowDuPont, the Agreements provide a framework for
Dow’s interaction with DuPont and Corteva after the separation and
also provide for the allocation among Dow, DuPont and Corteva of
assets, liabilities and obligations attributable to periods prior
to, at and after the completion of the separation. The Agreements
also contain certain indemnity and/or cross-indemnity provisions
that are intended to set forth each party’s respective rights,
responsibilities and obligations for matters subject to
indemnification. Except in certain instances, the parties’
indemnification obligations are uncapped. Certain indemnification
obligations will be subject to reduction by insurance proceeds or
other third-party proceeds of the indemnified party that
reduces the amount of the loss. In addition, indemnifiable losses
will be subject to, in certain cases, “de minimis” threshold
amounts and, in certain cases, deductible amounts.
The impacts of indemnifications and other post-separation matters
relating to the Agreements were primarily included in the
consolidated financial statements of Dow Inc. At June 30,
2021, the Company had assets of $31 million ($77 million
at December 31, 2020) included in "Other current assets" and
$32 million ($33 million at December 31, 2020) included
in "Noncurrent receivables," and liabilities of $215 million
($412 million at December 31, 2020) included in "Accrued
and other current liabilities" and $43 million
($46 million at December 31, 2020) included in "Other
noncurrent obligations" in the consolidated balance sheets of Dow
Inc. related to the Agreements.
In addition, the Company deferred a portion of the cash
distribution received from DowDuPont at separation and recorded an
associated liability in "Other noncurrent obligations," with an
offset to "Retained earnings" in the consolidated balance sheets of
Dow Inc. At June 30, 2021, $62 million ($103 million
at December 31, 2020) of this liability was recorded in
"Accrued and other current liabilities" and $96 million
($96 million at December 31, 2020) was recorded in "Other
noncurrent obligations" in the consolidated balance sheets of Dow
Inc.
NOTE 4 – REVENUE
Revenue Recognition
The majority of Dow's revenue is derived from product sales. Dow's
revenue related to product sales was 98 percent for the three
and six months ended June 30, 2021 (98 percent and 99 percent
for the three and six months ended June 30, 2020,
respectively), with the remaining balance primarily related to the
Company's insurance operations and licensing of patents and
technologies. Product sales consist of sales of Dow's products to
manufacturers and distributors and considers order confirmations or
purchase orders, which in some cases are governed by master supply
agreements, to be contracts with a customer. Dow enters into
licensing arrangements in which it licenses certain rights of its
patents and technology to customers. Revenue from Dow’s licenses
for patents and technology is derived from sales-based royalties
and licensing arrangements based on billing schedules established
in each contract.
Remaining Performance Obligations
Remaining performance obligations represent the transaction price
allocated to unsatisfied or partially unsatisfied performance
obligations. At June 30, 2021, Dow had unfulfilled performance
obligations of $851 million ($977 million at
December 31, 2020) related to the licensing of technology. Dow
expects revenue to be recognized for the remaining performance
obligations over the next six years.
The remaining performance obligations are for product sales that
have expected durations of one year or less, product sales of
materials delivered through a pipeline for which Dow has elected
the right to invoice practical expedient, or variable consideration
attributable to royalties for licenses of patents and technology.
Dow has received advance payments from customers related to
long-term supply agreements that are deferred and recognized over
the life of the contract, with remaining contract terms that range
up to 20 years. Dow will have rights to future consideration for
revenue recognized when product is delivered to the customer. These
payments are included in "Accrued and other current liabilities"
and "Other noncurrent obligations" in the consolidated balance
sheets.
Disaggregation of Revenue
Dow disaggregates its revenue from contracts with customers by
operating segment and business, as the Company believes it best
depicts the nature, amount, timing and uncertainty of its revenue
and cash flows.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Trade Sales by Segment and Business |
Three Months Ended |
Six Months Ended |
In millions |
Jun 30, 2021 |
Jun 30, 2020 |
Jun 30, 2021 |
Jun 30, 2020 |
Hydrocarbons & Energy |
$ |
2,008 |
|
$ |
787 |
|
$ |
3,759 |
|
$ |
2,006 |
|
Packaging and Specialty Plastics |
5,113 |
|
3,214 |
|
9,444 |
|
6,604 |
|
Packaging & Specialty Plastics |
$ |
7,121 |
|
$ |
4,001 |
|
$ |
13,203 |
|
$ |
8,610 |
|
Industrial Solutions |
$ |
1,201 |
|
$ |
894 |
|
$ |
2,250 |
|
$ |
1,948 |
|
Polyurethanes & Construction Chemicals |
3,012 |
|
1,520 |
|
5,568 |
|
3,508 |
|
Other |
2 |
|
3 |
|
4 |
|
6 |
|
Industrial Intermediates & Infrastructure |
$ |
4,215 |
|
$ |
2,417 |
|
$ |
7,822 |
|
$ |
5,462 |
|
Coatings & Performance Monomers |
$ |
1,010 |
|
$ |
766 |
|
$ |
1,865 |
|
$ |
1,594 |
|
Consumer Solutions |
1,455 |
|
1,089 |
|
2,723 |
|
2,326 |
|
Performance Materials & Coatings |
$ |
2,465 |
|
$ |
1,855 |
|
$ |
4,588 |
|
$ |
3,920 |
|
Corporate |
$ |
84 |
|
$ |
81 |
|
$ |
154 |
|
$ |
132 |
|
Total |
$ |
13,885 |
|
$ |
8,354 |
|
$ |
25,767 |
|
$ |
18,124 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Trade Sales by Geographic Region |
Three Months Ended |
Six Months Ended |
In millions |
Jun 30, 2021 |
Jun 30, 2020 |
Jun 30, 2021 |
Jun 30, 2020 |
U.S. & Canada |
$ |
4,927 |
|
$ |
2,944 |
|
$ |
8,955 |
|
$ |
6,494 |
|
EMEAI
1
|
5,102 |
|
2,711 |
|
9,431 |
|
6,122 |
|
Asia Pacific |
2,479 |
|
1,932 |
|
4,844 |
|
3,777 |
|
Latin America |
1,377 |
|
767 |
|
2,537 |
|
1,731 |
|
Total |
$ |
13,885 |
|
$ |
8,354 |
|
$ |
25,767 |
|
$ |
18,124 |
|
1.Europe,
Middle East, Africa and India.
Contract Assets and Liabilities
Dow receives payments from customers based upon contractual billing
schedules. Accounts receivable are recorded when the right to
consideration becomes unconditional. Contract assets include
amounts related to Dow's contractual right to consideration for
completed performance obligations not yet invoiced. Contract
liabilities include payments received in advance of performance
under the contract and are recognized in revenue when the
performance obligations are met. "Contract liabilities -
current" primarily reflects deferred revenue from prepayments from
customers for product to be delivered in 12 months or less and
royalty payments that are deferred and will be recognized in 12
months or less. "Contract liabilities - noncurrent" includes
advance payments that Dow has received from customers related to
long-term supply agreements and royalty payments that are deferred
and recognized over the life of the contract.
Revenue recognized in the first six months of 2021 from amounts
included in contract liabilities at the beginning of the period was
approximately $180 million (approximately $80 million in the first
six months of 2020). In the first six months of 2021, the
amount of contract assets reclassified to receivables as a result
of the right to the transaction consideration becoming
unconditional was insignificant (approximately $25 million in
the first six months of 2020).
The following table summarizes the contract assets and liabilities
at June 30, 2021 and December 31, 2020:
|
|
|
|
|
|
|
|
|
|
|
|
Contract Assets and Liabilities |
Balance Sheet Classification |
Jun 30, 2021 |
Dec 31, 2020 |
In millions |
Accounts and notes receivable - trade |
Accounts and notes receivable - trade |
$ |
6,456 |
|
$ |
4,839 |
|
Contract assets - current |
Other current assets |
$ |
51 |
|
$ |
58 |
|
Contract assets - noncurrent |
Deferred charges and other assets |
$ |
28 |
|
$ |
11 |
|
Contract liabilities - current
1
|
Accrued and other current liabilities |
$ |
211 |
|
$ |
349 |
|
Contract liabilities - noncurrent |
Other noncurrent obligations |
$ |
1,970 |
|
$ |
1,915 |
|
1.The
decrease from December 31, 2020 to June 30, 2021 was due to
recognition of deferred royalty payments.
NOTE 5 – RESTRUCTURING AND ASSET RELATED CHARGES - NET
Charges for restructuring programs and other asset related charges,
which includes asset impairments, are recorded in "Restructuring
and asset related charges - net" in the consolidated statements of
income and were $22 million for the three and six months ended
June 30, 2021 ($6 million and $102 million for the three
and six months ended June 30, 2020, respectively). For
additional information on the Company's restructuring programs, see
Note 6 to the Consolidated Financial Statements included in the
2020 10-K.
Restructuring Plans
2020 Restructuring Program
On September 29, 2020, the Board of Directors ("Board") of Dow Inc.
approved restructuring actions to achieve the Company's structural
cost improvement initiatives in response to the continued economic
impact from the coronavirus disease 2019 ("COVID-19") pandemic. The
restructuring program is designed to reduce structural costs and
enable the Company to further enhance competitiveness while the
COVID-19 economic recovery continues. This program includes a
global workforce cost reduction of approximately 6 percent and
actions to rationalize the Company's manufacturing assets, which
include asset write-down and write-off charges, related contract
termination fees and environmental remediation costs ("2020
Restructuring Program"). These actions are expected to be
substantially complete by the end of 2021.
In the second quarter of 2021, the Company recorded pretax
restructuring charges of $12 million for asset write-downs and
write-offs and $10 million for costs associated with exit and
disposal activities. The following table summarizes the activities
related to the 2020 Restructuring Program:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2020 Restructuring Program |
Severance and Related Benefit Costs |
Asset Write-downs and Write-offs |
Costs Associated with Exit and Disposal Activities |
Total |
In millions |
Packaging & Specialty Plastics |
$ |
— |
|
$ |
11 |
|
$ |
— |
|
$ |
11 |
|
Industrial Intermediates & Infrastructure |
— |
|
22 |
|
— |
|
22 |
|
Performance Materials & Coatings |
— |
|
117 |
|
57 |
|
174 |
|
Corporate |
297 |
|
47 |
|
24 |
|
368 |
|
Total restructuring charges |
$ |
297 |
|
$ |
197 |
|
$ |
81 |
|
$ |
575 |
|
Charges against the reserve |
— |
|
(197) |
|
— |
|
(197) |
|
Cash payments |
(1) |
|
— |
|
— |
|
(1) |
|
Reserve balance at Sep 30, 2020 |
$ |
296 |
|
$ |
— |
|
$ |
81 |
|
$ |
377 |
|
|
|
|
|
|
|
|
|
|
|
Performance Materials & Coatings |
$ |
— |
|
$ |
(1) |
|
$ |
4 |
|
$ |
3 |
|
Corporate |
— |
|
— |
|
(5) |
|
(5) |
|
Total restructuring charges |
$ |
— |
|
$ |
(1) |
|
$ |
(1) |
|
$ |
(2) |
|
Charges against the reserve |
— |
|
1 |
|
(5) |
|
(4) |
|
Cash payments |
(7) |
|
— |
|
— |
|
(7) |
|
Reserve balance at Dec 31, 2020 |
$ |
289 |
|
$ |
— |
|
$ |
75 |
|
$ |
364 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash payments |
(37) |
|
— |
|
(12) |
|
(49) |
|
Reserve balance at Mar 31, 2021 |
$ |
252 |
|
$ |
— |
|
$ |
63 |
|
$ |
315 |
|
Packaging & Specialty Plastics |
$ |
— |
|
$ |
— |
|
$ |
8 |
|
$ |
8 |
|
Industrial Intermediates & Infrastructure |
— |
|
1 |
|
— |
|
1 |
|
Performance Materials & Coatings |
— |
|
8 |
|
2 |
|
10 |
|
Corporate |
— |
|
3 |
|
— |
|
3 |
|
Total restructuring charges |
$ |
— |
|
$ |
12 |
|
$ |
10 |
|
$ |
22 |
|
Charges against the reserve |
— |
|
(12) |
|
— |
|
(12) |
|
Cash payments |
(53) |
|
— |
|
(3) |
|
(56) |
|
Reserve balance at Jun 30, 2021 |
$ |
199 |
|
$ |
— |
|
$ |
70 |
|
$ |
269 |
|
At June 30, 2021, $197 million of the reserve balance was
included in "Accrued and other current liabilities"
($227 million at December 31, 2020) and $72 million
was included in "Other noncurrent obligations" ($137 million
at December 31, 2020) in the consolidated balance
sheets.
The Company recorded pretax restructuring charges of
$595 million inception-to-date under the 2020 Restructuring
Program, consisting of severance and related benefit costs of
$297 million, asset write-downs and write-offs of
$208 million and costs associated with exit and disposal
activities of $90 million.
The Company expects to incur additional costs in the future related
to its restructuring activities. Future costs are expected to
include demolition costs related to closed facilities and
restructuring implementation costs; these costs will be recognized
as incurred. The Company also expects to incur additional
employee-related costs, including involuntary termination benefits,
related to its other optimization activities. These costs cannot be
reasonably estimated at this time.
NOTE 6 – SUPPLEMENTARY INFORMATION
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dow Inc. Sundry Income (Expense) – Net |
Three Months Ended |
Six Months Ended |
In millions |
Jun 30, 2021 |
Jun 30, 2020 |
Jun 30, 2021 |
Jun 30, 2020 |
Non-operating pension and other postretirement benefit plan net
credits
1
|
$ |
86 |
|
$ |
27 |
|
$ |
161 |
|
$ |
54 |
|
Foreign exchange losses |
(8) |
|
(2) |
|
(16) |
|
(18) |
|
|
|
|
|
|
Loss on early extinguishment of debt
2
|
(102) |
|
— |
|
(102) |
|
(86) |
|
|
|
|
|
|
Gains (losses) on sales of other assets and investments |
14 |
|
(4) |
|
62 |
|
5 |
|
Indemnification and other transaction related costs
3
|
(5) |
|
— |
|
(5) |
|
— |
|
Gain related to Nova ethylene asset matter
4
|
— |
|
6 |
|
— |
|
6 |
|
|
|
|
|
|
|
|
|
|
|
Other - net |
12 |
|
26 |
|
25 |
|
11 |
|
Total sundry income (expense) – net |
$ |
(3) |
|
$ |
53 |
|
$ |
125 |
|
$ |
(28) |
|
1.See
Note 16 for additional information.
2.See
Note 11 for additional information.
3.See
Note 3 for additional information.
4.See
Note 12 for additional information.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TDCC Sundry Income (Expense) – Net |
Three Months Ended |
Six Months Ended |
In millions |
Jun 30, 2021 |
Jun 30, 2020 |
Jun 30, 2021 |
Jun 30, 2020 |
Non-operating pension and other postretirement benefit plan net
credits
1
|
$ |
86 |
|
$ |
27 |
|
$ |
161 |
|
$ |
54 |
|
Foreign exchange losses |
(4) |
|
(6) |
|
(16) |
|
(23) |
|
|
|
|
|
|
Loss on early extinguishment of debt
2
|
(102) |
|
— |
|
(102) |
|
(86) |
|
|
|
|
|
|
Gains (losses) on sales of other assets and investments |
14 |
|
(4) |
|
62 |
|
5 |
|
Gain related to Nova ethylene asset matter
3
|
— |
|
6 |
|
— |
|
6 |
|
|
|
|
|
|
|
|
|
|
|
Other - net |
12 |
|
28 |
|
20 |
|
13 |
|
Total sundry income (expense) – net |
$ |
6 |
|
$ |
51 |
|
$ |
125 |
|
$ |
(31) |
|
1.See
Note 16 for additional information.
2.See
Note 11 for additional information.
3.See
Note 12 for additional information.
Accrued and Other Current Liabilities
“Accrued and other current liabilities” were $3,494 million and
$3,198 million at June 30, 2021 and $3,790 million and
$3,256 million at December 31, 2020, for Dow Inc. and
TDCC, respectively. Accrued payroll, which is a component of
"Accrued and other current liabilities" and includes liabilities
related to payroll, performance-based compensation and severance,
was $778 million at June 30, 2021 and $866 million at
December 31, 2020. No other components of "Accrued and other
current liabilities" were more than 5 percent of total current
liabilities.
NOTE 7 - EARNINGS PER SHARE CALCULATIONS
The following tables provide earnings per share calculations for
Dow Inc. for the three and six months ended June 30, 2021
and 2020. Earnings per share of TDCC is not presented as this
information is not required in financial statements of wholly owned
subsidiaries.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Income (Loss) for Earnings Per Share Calculations |
Three Months Ended |
Six Months Ended |
In millions |
Jun 30, 2021 |
Jun 30, 2020 |
Jun 30, 2021 |
Jun 30, 2020 |
|
Net income (loss) |
$ |
1,932 |
|
$ |
(217) |
|
$ |
2,938 |
|
$ |
41 |
|
Net income attributable to noncontrolling interests |
31 |
|
8 |
|
46 |
|
27 |
|
Net income attributable to participating securities
1
|
10 |
|
2 |
|
15 |
|
4 |
|
Net income (loss) attributable to common stockholders |
$ |
1,891 |
|
$ |
(227) |
|
$ |
2,877 |
|
$ |
10 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Earnings (Loss) Per Share - Basic and Diluted |
Three Months Ended |
Six Months Ended |
Dollars per share |
Jun 30, 2021 |
Jun 30, 2020 |
Jun 30, 2021 |
Jun 30, 2020 |
|
Earnings (loss) per common share - basic |
$ |
2.53 |
|
$ |
(0.31) |
|
$ |
3.86 |
|
$ |
0.01 |
|
Earnings (loss) per common share - diluted |
$ |
2.51 |
|
$ |
(0.31) |
|
$ |
3.83 |
|
$ |
0.01 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share Count Information |
Three Months Ended |
Six Months Ended |
Shares in millions |
Jun 30, 2021 |
Jun 30, 2020 |
Jun 30, 2021 |
Jun 30, 2020 |
|
Weighted-average common shares outstanding - basic |
747.0 |
|
739.3 |
|
745.9 |
|
739.7 |
|
Plus dilutive effect of equity compensation plans
2
|
5.9 |
|
— |
|
5.5 |
|
1.3 |
|
Weighted-average common shares outstanding - diluted
2
|
752.9 |
|
739.3 |
|
751.4 |
|
741.0 |
|
Stock options and restricted stock units excluded from EPS
calculations
3
|
3.8 |
|
27.7 |
|
4.8 |
|
17.3 |
|
1.Restricted
stock units are considered participating securities due to the
Company's practice of paying dividend equivalents on unvested
shares.
2.The
three months ended June 30, 2020 reflects a loss, and as such, the
basic share count was used for purposes of calculating earnings per
share on a diluted basis.
3.These
outstanding options to purchase shares of common stock and
restricted stock units were excluded from the calculation of
diluted earnings per share because the effect of including them
would have been antidilutive.
NOTE 8 – INVENTORIES
The following table provides a breakdown of
inventories:
|
|
|
|
|
|
|
|
|
Inventories |
Jun 30, 2021 |
Dec 31, 2020 |
In millions |
Finished goods |
$ |
4,144 |
|
$ |
3,140 |
|
Work in process |
1,414 |
|
996 |
|
Raw materials |
711 |
|
598 |
|
Supplies |
946 |
|
933 |
|
Total |
$ |
7,215 |
|
$ |
5,667 |
|
Adjustment of inventories to a LIFO basis |
(263) |
|
34 |
|
Total inventories |
$ |
6,952 |
|
$ |
5,701 |
|
NOTE 9 – NONCONSOLIDATED AFFILIATES
For additional information on the Company’s nonconsolidated
affiliates, see Note 12 to the Consolidated Financial Statements
included in the 2020 10-K.
The Company's investments in companies accounted for using the
equity method ("nonconsolidated affiliates"), by classification in
the consolidated balance sheets, and dividends received from
nonconsolidated affiliates are shown in the following
tables:
|
|
|
|
|
|
|
|
|
Investments in Nonconsolidated Affiliates |
Jun 30, 2021 |
Dec 31, 2020 |
In millions |
Investment in nonconsolidated affiliates |
$ |
1,754 |
|
$ |
1,327 |
|
Other noncurrent obligations |
(60) |
|
(169) |
|
Net investment in nonconsolidated affiliates |
$ |
1,694 |
|
$ |
1,158 |
|
|
|
|
|
|
|
|
|
|
Dividends Received from Nonconsolidated Affiliates |
Six Months Ended |
In millions |
Jun 30, 2021 |
Jun 30, 2020 |
Dividends from nonconsolidated affiliates
1
|
$ |
219 |
|
$ |
380 |
|
1.Included
in "Earnings of nonconsolidated affiliates less than (in excess of)
dividends received" in the consolidated statements of cash flows.
At June 30, 2020, the Company had $109 million of dividends
receivable included in "Accounts and note receivable - Other" in
the consolidated balance sheets.
At June 30, 2021, the Company had a negative investment
balance in
EQUATE Petrochemical Company K.S.C.C.
of $60 million (negative $147 million at
December 31, 2020), included in "Other noncurrent obligations"
in the consolidated balance sheets.
At June 30, 2021, the Company had an investment balance in
Sadara Chemical Company (“Sadara”) of $350 million included in
“Investment in nonconsolidated affiliates” (negative $22 million at
December 31, 2020 included in “Other noncurrent obligations”) in
the consolidated balance sheets. In the first quarter of 2021, the
Company entered into a new guarantee in conjunction with Sadara’s
debt re-profiling activities. In the second quarter of 2021, as a
part of Sadara's debt re-profiling activities, Sadara established a
new revolving credit facility guaranteed by Dow, which will be used
to fund Dow’s pro-rata share of any potential shortfall during the
grace period. The Company does not expect to be required to perform
under the guarantee. See Notes 12 and 19 for additional
information on the guarantees.
Transactions with Nonconsolidated Affiliates
The Company is currently responsible for marketing the majority of
Sadara products outside of the Middle East zone through the
Company’s established sales channels. Under this arrangement, the
Company purchases and sells Sadara products for a marketing fee. In
March 2021, Dow and the Saudi Arabian Oil Company agreed to
transition the marketing rights and responsibilities for Sadara’s
finished products to levels more consistent with each partner’s
equity ownership. This transition began in July 2021 and will be
implemented over the next five years.
NOTE 10 – GOODWILL AND OTHER INTANGIBLE ASSETS
The following table shows changes in the carrying amount of
goodwill by reportable segment:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Goodwill |
Packaging & Specialty Plastics |
Industrial Intermediates & Infrastructure |
Performance Materials & Coatings |
Total |
In millions |
Net goodwill at Dec 31, 2020 |
$ |
5,115 |
|
$ |
1,100 |
|
$ |
2,693 |
|
$ |
8,908 |
|
|
|
|
|
|
Foreign currency impact |
(4) |
|
(2) |
|
(69) |
|
(75) |
|
Net goodwill at Jun 30, 2021 |
$ |
5,111 |
|
$ |
1,098 |
|
$ |
2,624 |
|
$ |
8,833 |
|
The following table provides information regarding the Company’s
other intangible assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other Intangible Assets |
Jun 30, 2021 |
Dec 31, 2020 |
In millions |
Gross Carrying Amount |
Accum Amort |
Net |
Gross Carrying Amount |
Accum Amort |
Net |
Intangible assets with finite lives: |
|
|
|
|
|
|
Developed technology |
$ |
2,638 |
|
$ |
(1,780) |
|
$ |
858 |
|
$ |
2,638 |
|
$ |
(1,677) |
|
$ |
961 |
|
Software |
1,500 |
|
(1,030) |
|
470 |
|
1,489 |
|
(989) |
|
500 |
|
Trademarks/tradenames |
352 |
|
(344) |
|
8 |
|
352 |
|
(343) |
|
9 |
|
Customer-related |
3,253 |
|
(1,496) |
|
1,757 |
|
3,301 |
|
(1,419) |
|
1,882 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total other intangible assets |
$ |
7,743 |
|
$ |
(4,650) |
|
$ |
3,093 |
|
$ |
7,780 |
|
$ |
(4,428) |
|
$ |
3,352 |
|
The following table provides information regarding amortization
expense related to intangible assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amortization Expense |
Three Months Ended |
Six Months Ended |
In millions |
Jun 30, 2021 |
Jun 30, 2020 |
Jun 30, 2021 |
Jun 30, 2020 |
Other intangible assets, excluding software |
$ |
100 |
|
$ |
100 |
|
$ |
201 |
|
$ |
200 |
|
Software, included in “Cost of sales” |
$ |
23 |
|
$ |
24 |
|
$ |
45 |
|
$ |
48 |
|
Total estimated amortization expense for 2021 and the five
succeeding fiscal years, including amounts expected to be
capitalized, is as follows:
|
|
|
|
|
|
Estimated Amortization Expense |
In millions
|
2021 |
$ |
477 |
|
2022 |
$ |
414 |
|
2023 |
$ |
381 |
|
2024 |
$ |
362 |
|
2025 |
$ |
270 |
|
2026 |
$ |
198 |
|
NOTE 11 – NOTES PAYABLE, LONG-TERM DEBT AND AVAILABLE CREDIT
FACILITIES
|
|
|
|
|
|
|
|
|
Notes Payable |
Jun 30, 2021 |
Dec 31, 2020 |
In millions |
|
|
|
Notes payable to banks and other lenders |
$ |
203 |
|
$ |
156 |
|
|
|
|
|
|
|
Period-end average interest rates |
5.76 |
% |
3.89 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Long-Term Debt |
2021 Average Rate |
Jun 30, 2021 |
2020 Average Rate |
Dec 31, 2020 |
In millions
|
Promissory notes and debentures: |
|
|
|
|
Final maturity 2021 |
8.85 |
% |
$ |
53 |
|
8.95 |
% |
$ |
173 |
|
Final maturity 2022 |
8.64 |
% |
121 |
|
8.64 |
% |
121 |
|
Final maturity 2023 |
7.63 |
% |
250 |
|
7.63 |
% |
250 |
|
Final maturity 2024 |
— |
% |
— |
|
3.43 |
% |
1,017 |
|
Final maturity 2025 |
5.13 |
% |
625 |
|
5.13 |
% |
625 |
|
Final maturity 2026 |
3.63 |
|